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DEVELOPING CULTURE MEDIA TO STUDY KERATOCYTE PHENOTYPES
IN VITRO
Kurt Musselmann
ABSTRACT

The corneal wound healing response involves the activation of keratocytes
to proliferate from a quiescent phenotype. The mitogens that cause the initial
transformation of the quiescent keratocytes to the active phenotype have not
been identified. Even though serum is commonly used to replicate this in vitro,
the cornea is avascular and therefore likely not exposed to serum. In the first
part of this dissertation, a DMEM/F12 extract of corneal stromas was made and
shown to stimulate keratocyte proliferation in both a dose-dependent and celldensity dependent manner. This extract contains mitogens that differ from the
mitogens present in serum based on their effect on keratocytes and their
biochemical characteristics. Culture in extract replicates in vitro the changes
observed during the activation of keratocytes in the wound-healing phase.
The corneal stroma contains an extensive extracellular matrix that
consists primarily of collagens and proteolgycans. This matrix is maintained and
secreted by the keratocytes, cells with unique characteristics lost during the
activation observed at wound healing. The second part of this dissertation aims
xi

to develop a defined culture medium that maintains the keratocyte phenotype
during proliferation. Keratocytes were cultured in serum-free medium and the
effect of the growth factors on the markers for the keratocyte phenotype
determined. Only insulin was shown to stimulate cell proliferation in a consistent
manner, while maintaining commonly accepted keratocyte markers. When this
defined culture medium was supplemented with ascorbic acid to study collagen
synthesis, a marked increase in both collagen synthesis and keratan sulfate
proteoglycan accumulation was measured. This newly developed culture
medium, containing insulin and ascorbate, allows for cell growth, maintains the
keratocyte markers, and could be used to study the native, non-activated
keratocyte phenotype in culture.
This dissertation shows that the culture media described herein replicate
in vitro all the phenotypes observed during the corneal wound healing response
in vivo. These culture media, in turn, could be used to obtain more knowledge
about the different keratocyte phenotypes, and how they could be manipulated in
culture. (329 words)

xii

INTRODUCTION
THE CORNEA
The cornea is the outermost refractive layer of the optic system and
initially forms via the separation of ectodermal tissue from the lens (1). This
ectodermal tissue gives rise to the corneal epithelium, which secretes an initial
collagenous matrix that serves as a substratum for the migration of cells of
neural-crest origin. The migration of these cells can occur in one or two waves,
depending on the species (2). As an example, in mice, the first wave of neural
crest derived cells forms the corneal endothelium.

These cells modify the

collagenous matrix by secreting hyaluronan. Upon the closure of the endothelial
cell sheet, the collagenous matrix thickens and then the second wave of neuralcrest derived cells, the precursors for the keratocytes, migrate and populate the
matrix (2). At this developmental stage, the corneal stroma is rich in hyaluronan,
decorin and contains collagen (3). When the stroma has been completely
populated by mesenchymal cells, the level of stromal hyaluronan gradually
decreases. These cells remodel the collagenous matrix and secrete unsulfated
lumican as well as unsulfated keratocan during the initial phase of corneal growth
(4); these proteins are important for the modulation of collagen fibril diameter (5).
During

the

maturation

process

the

cornea

thickens

and

the

glycosaminoglycan composition of the extracellular matrix changes. At birth, the
1

mouse cornea is around 60µm thin (2) and contains unsulfated lumican or
undersulfated lumican in the stroma (6). The epithelium is composed of only one
to two stacked cell layers.

Its thickness increases from birth to after eyelid

opening, accelerating after lid opening and becoming 5-7 cell layers deep (2).
Stromal thickness increases by almost 60% to around 100µm between
birth and eyelid opening time. This is due to increased matrix synthesis and
modification by the cells present in the stroma, and occurs even though the
number of cells decreases (6,7). The thickening of the stroma correlates with an
increase in the sulfation and in the levels of the main KSPGs (8,9): lumican and
keratocan, and this increased negative charge causes inflow of water into the
stroma (6).

In the developing mouse, this thickening reaches its maximum

shortly after eyelid opening and then decreases slightly to the adult level and
then remains constant (6). This decrease in stromal thickness provides evidence
that the pumping function of the corneal endothelium initiates after eyelid opening
and stromal thickening, and serves to compact the stroma as the cornea gains its
transparency.

In contrast to the expression of keratocan, which decreases

through adulthood, the expression of lumican is high and remains constant. The
resulting cornea is a thin (500 µm in humans, 300 µm in rats), avascular and
uniquely transparent organ responsible for most of the refractive action of the eye
(10,11). It contains the three tissue layers (Figure 1), each separated from the
other by basement membranes.

2

Figure 1. Cross section through a rat stroma. The three tissue layers and the
cells comprising them are visible.

Legend: yellow (dashed arrow) indicates proliferation (Ki67, a cell-cycle marker);
red fluorescence (short arrows) staining for DNA in the stroma(propidium iodide).
Arrow shows the endothelial cell layer.
Modified from Zieske et al, 2001 (64). Used with permission from the orginal
author and from Elsevier. Reprinted from Experimental Eye Research, 72 (1): 33
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Bowman’s membrane separates the epithelium from the stroma, and
Descemet’s membrane separates the stroma from the endothelium (10). The
stratified corneal epithelium prevents leakage of external fluids into the corneal
stroma and serves as a barrier to environmental agents like bacteria, fungi and
viruses (12-15) due to the tight junctions formed between the cells (10,14-17). In
combination with the tear film, the epithelium forms a smooth surface of the
cornea (11). The epithelium is regenerated on a continuous basis (10) from the
stem cells located in the limbal epithelium (18). Between the basal lamina of the
corneal epithelium and the stroma is Bowman’s membrane, a 4 µm thin layer that
contains high levels of collagen types I, III and V (19). Like basement
membranes, this layer also contains collagen type IV, laminin, as well as
perlecan, a heparan sulfate proteoglycan.

It is a dense, felt-like sheet

characterized by the presence of collagen fibrils of thin diameter, mainly due to
the high levels of collagen type V (19).
Even though the exact function or the cellular origin of Bowman’s
membrane is not known (20), it has been proposed that this layer may originate
from the concerted action of keratocytes and epithelial cells and may serve as a
cell-free zone to prevent pathogen infections of the stroma after epithelial
damage. It has been reported that the absence of this layer in vivo causes
epithelial cells to exhibit a morphology that differs from their normal phenotype
(21). This layer is not present in all animals and its presence appears to be
developmentally regulated in rabbits (22). Immunohistochemical staining studies
show that several growth factors released by epithelial cells bind to Bowman’s
4

membrane, possibly making this layer a growth factor sink (23). In adult rabbits
without Bowman’s membrane, the epithelial basement membrane prevents the
passage of TGF-b 2 made by the epithelium into the stroma. These growth
factors, however, are released by the degradation of the basement membrane
after damage or proteolytic degradation (20,23,24).
The corneal stroma is the most organized extracellular matrix (ECM) in the
body, accounting for approximately 90% of corneal thickness and is composed of
collagens and proteoglycans. The collagen fibrils are organized into lamellae
that are orthogonal to each other and also to the path of light (shown in Figure 2,
left panel). The fibrils are of uniform diameter (~30 nm) and regularly spaced
(~60 nm from center to center)(Figure 2, center panel, collagen fibrils stained
with OsO4). The proteoglycans in the stroma interact with the collagen and fill
the spaces between fibrils (Figure 2, right panel, stained with Cuperionic blue
(25). Collagens comprise around 80% of total corneal protein. Collagens are
proteins characterized by the presence of at least one triple helical domain, and
the presence of (Gly-X-Y)n repeats, with x being proline and Y being
hydroxyproline (26).

Based on their supramolecular structure, collagens are

separated into fibrilar collagens, fibril associated collagens, membrane collagens
and multiplexins. Multiplexins are collagenous proteins with multiple triple-helical
domains and also are proteoglycans (26). In the cornea, collagen type I is the
most abundant (~75% of total collagen), followed by collagen type VI and
collagen type V (around 15% and 10%, respectively) (27,28).

5

Figure 2.

Collagen organization and ECM staining for collagen and

proteoglycans. Left Panel: Schematic of collagen lamellae organization in the
cornea. The collagen fibrils within each lamellae are parallel to each other but
orthogonal to collagen fibrils in the neighboring lamellae.
Legend: OsO4: stains collagen; CuB: stains proteoglycan side chains. Sectioning
performed parallel to the direction of collagen within lamellae (A-D) or in cross
section (E-F).

Modified from Mueller et al., 2004 (25).

permission both from the author and also from Elsevier.
Experimental Eye Research, 78 (3): 493
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Figure used with
Reprinted from

Collagen type VI binds proteoglycans (29) and has been shown to form thin
filaments in the stroma (30,31). Collagen type I and V are both members of the
fibrilar collagens and similar to other ECMs, form thin heterofibrils (32,33). In
contrast to Bowman’s membrane where immunostaining readily detects collagen
V, the detection of this collagen in the stroma requires that the collagen fibrils first
be disrupted (33), indicating that this collagen is buried inside the collagen fibril.
Both collagen type I and collagen type V are secreted as procollagen
polypeptides and require posttranslational processing to remove the procollagen
domains to form mature collagen. Procollagen type I is completely processed to
the mature form, but mature collagen type V still retains a portion of its globular,
non-collagenous N-terminal domain (34). This remnant does not inhibit the
incorporation of collagen type V into fibrils (35,36) and has been shown to project
through gaps in the collagen fibril (34).

In fact, Birk et al. have shown that

collagen V controls the initiation of collagen fibril formation (37) and also that
collagen fibril diameter is inversely proportional to collagen type V content
(38,39), which likely inhibits lateral fibril growth by steric and charge interactions
(34).
The three main proteoglycans in the stroma are decorin (40), keratocan
(41) and lumican (8,42-44), while osteoglycin/mimecan (45) is found at lesser
amounts. These proteins are members of the small, leucine-rich proteoglycan
(SLRP) gene family and have a similar primary structure with several identifiable
leucine-rich repeats (LRR) and are post-translationally modified by the addition of
either

chondroitin

sulfate

(CS)

or
7

keratan

sulfate

(KS)

(8,43,44,46)

glycosaminoglycan (GAG) side chains.

Decorin is a CS proteoglycan; and

keratocan, lumican and mimecan are KS proteoglycans. Homology modeling to
ribonuclease inhibitor, a LRR protein with a known crystal structure, predicts that
proteins with multiple LRR adopt a solenoid tertiary structure (47), with the
proteoglycan chains extending outwards from the protein. The presence of LRR
repeats is important for protein-protein interactions (47,48) and the core proteins
of decorin, lumican and keratocan have been shown to affect collagen fibril
formation and stability in vitro. Lumican and keratocan null-mice exhibit larger
collagen fibril diameters, suggesting that these proteoglycans bind and modulate
collagen fibril growth in vivo as well, and that the absence of one cannot be
rescued by the other proteoglycan.
Keratan sulfate GAGs account for around 60% of the GAGs in the stroma,
and chondroitin sulfate for around 40% (49). Electron micrographs show that
these GAGs extend from the collagen fibrils into the stromal matrix, filling the
spaces between the collagen fibrils (Figure 2) (25). The high negative charge of
the sulfated GAGs causes both water inflow between the fibrils and also
electrostatic repulsion between side chains and this helps to maintain collagen
fibril spacing. The protein core of these proteoglycans, however, does interact
with the collagen fibrils directly, most probably via the LRRs. This interaction can
be measured in vitro by following collagen fibril formation in the presence of
these proteins by turbidimetry (44,50). The collagen fibrils that are formed in the
presence of the core proteins not only are different in diameter, but also show
different formation kinetics (51). The reduction and alkylation of the core protein
8

eliminated the modulatory activity of the proteoglycans, but the removal of the
GAG side chain did not, suggesting that only the core protein interacts with and
modulates collagen fibril formation (44).
Lumican and keratocan null-mice have significantly thinner corneas than
the wild-type animals, and the stromas of the lumican and the keratocan nullmice exhibit a reduction in collagen fibril homogeneity and spacing (6,52). The
loss of lumican, the major KSPG in the corneal stroma, is not rescued by
keratocan, and collagen fibrils increase in diameter and the fibrils are irregular in
shape, confirming the importance of these proteoglycans for the structure of the
cornea.

Keratan sulfate is a repeating dissacharide of glucosamine and

galactose that is decorated with sulfate esters. Defects in the sulfation of the
repeating disaccharide (53) results in a disease phenotype known as Macular
Corneal Dystrophy. Patients suffering from macular corneal dystrophy have
thinner corneas, mainly due to reduced spacing between the collagen fibrils. The
main defect in MCD, however, is the accumulation of opaque deposits in the
corneal stroma (54). Biochemical analysis has shown that these deposits contain
mature lumican and keratocan core proteins, but instead of being substituted with
keratan sulfate side chains, they contain the unsulfated polylactosamine chains
(54). These chains are insoluble in aqueous solutions and likely cause the
proteoglycans to precipitate.

As the expression of lumican and keratocan

increase during corneal transparency, the deposits increase in size, leading to
the opacification of the cornea.

9

While both chondroitin sulfate (CS) and keratan sulfate (KS) bind water,
KS is more hygroscopic than CS, but binds water less tightly. As previously
mentioned, the KS content of the stroma is higher in the posterior stroma
compared to the anterior stroma. As a consequence of the high GAG content,
the cornea is prone to swelling. Excess water inflow would result in edema,
causing the cornea to swell and become opaque. This, however, does not occur
in healthy corneas, because to the pumping action of the endothelium (55). This
pumping action removes water from the stroma into the aqueous humor. The
endothelium also plays a role in the nourishment of the cells in the stroma(55).
The lack of vasculature in the cornea combined with the tight junctions of the
epithelium prevents the corneal stroma from being nourished directly from
diffusion from blood vessels or from the tear film. In contrast, endothelial cells
form leaky junctions. These allow nutrients to enter the stroma through diffusion
from the aqueous humor and feed the keratocytes. Endothelial cells are also
responsible for the secretion of collagens and other matrix components of
Descemet’s membrane (56).

THE KERATOCYTE
Unlike other extracellular matrices (ECM), where keratan sulfate is present
in only minor amounts, the ECM of the cornea has very high levels of keratan
sulfate. This is the reason these cells are called keratocytes. Keratocytes are
dispersed throughout the stroma and form a three-dimensional network of cells
that interact via gap junctions (57-61). They have a large, rounded cell body (60)
10

and a dendritic morphology containing both large and small processes or
lamellipodia.
It has been shown that both cell density and the branching of the dendrites
decreases as distance from the epithelium increases (57,62). The reason for this
is not understood, but may be related to differences in the local composition of
the ECM and partial oxygen pressure in the tissue surrounding these cells.
These cells are locked in G0, or quiescent (63,64), but are not senescent. These
cells maintain the stroma by synthesizing and remodeling the collagen fibrils and
proteoglycans present in it (65). Keratocytes secrete large amounts of the
KSPGs. While lumican and mimecan are found in other tissues in the body,
keratocan is the only KSPG that is primarily expressed in the cornea.
Keratocan is likely important for the maintenance of proper corneal
curvature. This has been suggested by the clinical appearance of patients with
Cornea Plana, which is caused by defects in the keratocan gene. Cornea Plana
is characterized by a marked flattening of the corneal curvature, which in turn
lowers the refractive power of the stroma. Besides their high levels of keratan
sulfate expression, the in-situ keratocytes are also characterized by the
expression of housekeeping enzymes at very high levels (66). These enzymes,
like ALDH, can comprise 30% of the water-soluble protein in the cell (67-70).
Other proteins expressed at high levels are transketolase and G3DPH (71). Even
though ALDH and transketolase are important for the removal of UV-irradiation
by-products (68), the high cellular contents suggests that these proteins may
have a different role than their purely metabolic one (69,72-74). These proteins
11

are also expressed at very high levels in the lens (up to 90% of total protein) and
are called crystallins (75-77). The crystallins (71) are thought to play an important
role in the cellular component of corneal transparency (78).

It has been

proposed that these proteins minimize the difference in refractive index between
the cells and the ECM, but it also has been proposed that the high levels of these
proteins cause destructive interference in light passing through the cells (79).
Keratocytes in-situ also express collagen-binding integrins like a3b1 and avb1
(80,81). Other cell surface markers for keratocytes are CD34 (82) and 3G5 (83).
Anatomically, these cells contain cortically organized f-actin, and lack prominent
focal adhesions (84).
When the cornea is wounded, some of the surviving keratocytes in the
stroma re-enter the cell cycle.

This transformation from a quiescent cell

phenotype to a mitotically active phenotype, has been termed “activation”. The
activated keratocytes are proliferative, express α5β1 integrin (the fibronectin
receptor) on their cell-surface (81) and are migratory. A re-organization of the
previously cortically found f-actin takes place and f-actin stress fibers anchored at
focal adhesions (84) are formed. Besides these changes, activated keratocytes
synthesize and secrete fewer KSPGs and increase CSPG synthesis and
secretion (43).

Also, a decrease in cellular crystallin levels increases

interference with light passing through the cells, making them less transparent
and thereby increasing stromal haze (85). High levels of crystallins are therefore
usually used as a marker of the keratocyte phenotype, and their loss, combined
with other markers like cell migration, increased CS synthesis and stress fiber
12

formation, are used as indicators that these cells have become activated (86). It
is possible that this decrease in cellular crystallins is partially due to the dilution
of these proteins by cell division, although a recent study suggests that the cells
may be degrading these proteins while in the activated state (87).
A third keratocyte phenotype, the myofibroblasts, is usually observed in
the healing phase of incisional corneal wounds.

Myofibroblasts remain

proliferative and migratory, and also express alpha smooth-muscle actin (aSMA).
As with activated keratocytes, myofibroblastic keratocytes do not have high
cytosolic ALDH levels, and therefore interfere with light passing through the
cornea. The induction of the myofibroblastic phenotype has been shown to be
due to the action of TGF-β (88-90) but also requires actin reorganization and
PDGF signaling (91). It has also been shown that TGF-β stimulation of corneal
fibroblasts results in the increased expression of TGF-β, PDGF and FGF-2 in an
autocrine manner (91,92). These cells, like the activated keratocytes, continue to
express the α5β1 integrin on their cell surface (81). Myofibroblasts also secrete
an ECM that is considerably different than the matrix secreted by quiescent and
activated keratocytes.

KSPG expression remains low (93), but collagen type III

synthesis and secretion increases considerably, as do the synthesis and
secretion of fibronectin, laminin, biglycan, perlecan and SPARC (86,94). The
synthesis and secretion of these proteins, therefore, are markers for the
myofibroblastic phenotype in vivo. The synthesis and secretion of these fibrotic
ECM components disrupt the crystal-like organization of the stromal ECM,
resulting in increased scattering of light, detectable as corneal haze (79). It is not
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known if myofibroblasts in-situ revert to the fibroblastic phenotype or the
keratocyte phenotype.

Some evidence exists, however, that myofibroblasts

undergo apoptotic cell death during the resolution of the wound, similar to what is
observed in healed skin wounds (95-97).
Traditionally, keratocytes were isolated and cultured in medium containing
10% fetal bovine serum (FBS). Cells cultured in serum proliferate rapidly, and
populations can be expanded and passaged. While this is an advantage and
allows for an increase in cell number, it also results in the keratocytes losing their
characteristic dendritic morphology and adopting a spindle-shaped, fibroblastic
morphology (94), but some of the cells also become myofibroblastic (98).

Due

to their morphology, these cells are commonly referred to in the literature as
corneal/stromal fibroblasts (86,94,99,100).

The cytosolic levels of ALDH

decrease, as do the synthesis and secretion of keratocan and the other keratan
sulfate proteoglycans. Chondroitin sulfate synthesis, however, increases (40) in
a manner similar to cells of the activated phenotype (99). Serum is therefore
thought to recreate the activated phenotype in vitro. When growth stimulation by
serum is removed, the cells restore their dendritic morphology, secrete more
keratocan and keratan sulfate proteoglycans, but not gain the high cytosolic
ALDH levels (100). These findings resulted in the suggestion that the dendritic
morphology also be considered a marker for the keratocyte phenotype.
Culture of rabbit keratocytes directly in serum-free media was shown to
prevent the induction of the presumed activated phenotype (98) and this was
adapted to bovine keratocytes by Beales et al. (99) where cells are plated in 1%
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platelet poor horse serum (PPHS), which is essentially plasma, and changed to
serum-free medium on day 1 (harvesting day is day 0, and the cells are allowed
to attach overnight and treated on day 1).

Under these culture conditions,

keratocytes remain mostly quiescent and maintain their dendritic morphology
(Figure 3).
F-actin is detected cortically (Figure 4A). These cells also maintain high
cytosolic ALDH levels, as well as synthesize and secrete keratan sulfate and
chondroitin sulfate proteoglycans similar to the in-situ keratocytes, therefore this
method is commonly used to study the keratocyte phenotype in vitro. However,
the disadvantage of this culture condition is that cells do not proliferate and cell
numbers decrease over the course of culture.
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Figure 3. Keratocyte morphology in high density cell cultures. Keratocytes
isolated by collagenase and plated in 1% platelet poor horse serum. The cells
maintain a dendritic morphology, and lamellipodia connect neighboring cells.
Keratocytes measure around 100 µm in diameter.

16

Figure 4. F-actin staining of keratocytes in culture. (A). Keratocytes cultured
in 1%PPHS alone or supplemented with 1ng/ml TGF-β for 6 days (B). Cells were
stained for f-actin (green, arrow) or paxilin (red, arrowhead). F-actin and paxilin
staining in the myofibroblasts shows that the actin filaments are anchored at focal
contacts.

Figure by Funderburgh et al. (270) from the Journal of Biological

Chemistry, Nov 2001(276):44173. (No copyright request needed to use figure in
thesis).
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Activated keratocytes are transformed to the myofibroblastic phenotype,
by adding TGF-b to the 10% serum-containing culture medium. These cells have
prominent stress fibers that are anchored at prominent focal adhesions (Figure
4B) and secrete the fibrotic ECM markers previously described. These cells also
express aSMA in their cytosol.

While it is commonly assumed that bovine

keratocytes require both serum and TGF-b to become myofibroblastic, current
evidence suggests that the presence of TGF-b alone in the medium is sufficient
(101).

This transformation, however, is slow and thought to be due to the

autocrine secretion of growth factors by the cells exposed to TGF-b.

The

transformation is sped up if the cells are cultured in medium containing growth
factors. Masur et al. (102) have showed that rabbit keratocytes can become
myofibroblastic when plated at low density and are grown to confluence in serum
and Jester et al. (101) have shown that they also become myofibroblastic in SFM
supplemented with TGF-b. This suggests that quiescent rabbit keratocytes
respond to TGF-b, and that these cells produce autocrine TGF-b when grown in
serum, which then induces the myofibroblast phenotype. The myofibroblastic
phenotype, at least in rabbits, can be reversed by the addition of FGF-2 and
heparin to the culture medium (103), or by re-plating the myofibroblasts at high
density (102). It is not yet known, however, if this reversion also occurs in vivo.
Jester et al, as well as Mohan et al. (95), have presented evidence that
myofibroblasts undergo apoptotic cell death upon wound resolution. The
identification of markers for each keratocyte phenotype allows researchers to
determine if their culture conditions cause phenotypic changes of these cells.
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CORNEAL WOUND HEALING
Several excellent reviews of the interactions between the corneal
epithelium and stroma during wound healing, and of the cytokines involved in the
process can be found in the literature (64,104-110). After wounding, cytokines
made and secreted by epithelial cells, like IL-1 and TGF-β, can enter the stroma
if the basement membrane has been disrupted. IL-1 stimulates the expression of
FAS-ligand by keratocytes, and this has been implicated in the resulting
apoptosis of the keratocytes (107). The TGF-β secreted by the epithelium, which
enters

the

stroma

after

basement

membrane

myofibroblastic transformation of the keratocytes.

disruption,

causes

the

Other cytokines, made by

keratocytes like HGF and KGF, have been shown to stimulate epithelial cell
migration, as has lumican, one of the corneal KSPGs.

These interactions,

between the epithelium and stroma make it difficult to study the healing response
of the cells in the stroma alone. The study of a purely stromal wound healing
response, however, has been facilitated by the development of LASIK eye
surgery. In this type of refractive surgery, a stromal-epithelial flap is created
using a microkeratome and results in only localized epithelial-basement
membrane disruption at the flap edge, with most of the ‘wound area’ created
inside the corneal stroma. The wound healing response will be described briefly
later.
The density of the cells in the stroma decreased considerably after corneal
wounding (111). Most studies attributed this rapid decrease to cellular damage
Figure 5.that occurred during the wounding process (95). It is now accepted,
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however, that this decrease is due to both necrotic and apoptotic cell death
(64,109,112-115). While the exact reasons and initiators of the apoptotic event
are not known, several possible candidates have been identified. IL-1, PAF,
FAS-ligand have all been shown to cause apoptosis in keratocytes in vivo and in
vitro (96,110,116,117).

These cytokines are released by the damaged

epithelium, Bowman’s membrane or are present in tear fluid (105,107,118).
However, keratocyte apoptosis is also observed even if the cornea merely
experiences pressure exerted on it by a lens or ring (119), indicating that
epithelial damage or stromal disruption is not required for the apoptotic response.
This apoptotic event is not limited to cells immediately in the injury site, but
results in the formation of a relatively large cell-void space in the cornea adjacent
to the wound site (95,111).

Because most animals require visual acuity to

survive, this has led to the theory that the rapid loss of keratocytes is an
evolutionary mechanism to prevent infection of keratocytes by pathogens (115)
upon epithelial barrier damage.
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Figure 5. Scrape injury wound healing. (from Zieske et al., 2001) shows the
healing of a corneal scrape wound in rat over 10 days (64). Figure used with
permission both from the original author and also from Elsevier. Reprinted from
Experimental Eye Research, 72,(1) 33-39.

Sections were stained with

propidium iodide (red for DNA) and with Ki67 (green, marker of cell cycle).
Arrows in Panel B (8-hours) indicate the original margin of the epithelial scrape.
Arrows in Panels C and F (24-hours and 120-hours, respectively) indicates
proliferating keratocytes staining positive for Ki67.
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Figure 5.
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In the top panel, which shows the cornea prior to wounding, only 30-40%
of the epithelial cells stain positive for Ki67, indicating that they are dividing. No
positive cells are observed in the stroma or endothelium.

Eight hours after

scraping, the cells in the anterior stroma, adjacent to the wound have
disappeared (apoptosis).

After wounding and within 24 hours, the corneal

epithelium loosens its attachments to the basement membrane, the cells flatten
and migrate over the exposed basement membrane as a sheet and close the
defect (Figure 5). Among factors that facilitate epithelial cell migration are KGF,
HGF, IGF-1 and PDGF, as well as the fibronectin deposited during wound
healing (110,120). Individual keratocytes adjacent to the cell-void area now stain
positive for Ki67, indicating that they have left G0 and entered the cell cycle, and
have become activated. After 28 hours, and coverage of the epithelial defect,
basal cells of the corneal epithelium enter the cell cycle and start to proliferate to
re-form the stratified epithelium.

The anterior stroma now stains for DNA,

however, these cells are not proliferating, and Zieske et al. (64) speculate that
these cells are inflammatory cells that migrate into the anterior stroma to take
care of any pathogens that may have entered the stroma after injury.
In the stroma, within 12-24 hours post wounding and the apoptotic event,
the keratocytes surrounding the cell-void space become activated, re-enter the
cell cycle and become migratory (64,113,115,121). It is not yet known what
causes these cells to activate, but it has been proposed that keratocyte activation
involves cytokines that are released by the damaged epithelium or by the
apoptotic response of the keratocytes. By 44 hours, the posterior stroma stains
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strongly for Ki67, indicating that many of these cells have entered the cell cycle.
By 120 hours, only the anterior stroma stains for Ki67, suggesting that in the
posterior stroma the keratocytes have exited the cell cycle, likely due to cell-cell
contact inhibition. Only cells that have space to grow, in the anterior stroma,
proliferate. By 240 hours, both staining for Ki67 and propidium iodide in the
epithelium and the stroma resemble the staining prior to wounding. The wound
healing response in this model did not result in any cells staining positive for
aSMA, indicating that the healing process involved activated keratocytes only
and not myofibroblastic keratocytes. Corneal fibroblasts have been shown to
either produce or express receptors to BMP 2 and 4, EGF, FGF-2, IGFs I and II,
insulin, LPA, PDGF and TGF-b (122-125). With the exception of TGF-β 1 and 2,
all these growth factors have been shown to stimulate cell growth (125).
Maintaining the integrity of Bowman’s membrane or the basement membrane
prevents the entry of TGF-β 2 into the stroma. In these cases, as shown above,
the wound healing occurs without the myofibroblastic transformation of the cells
(126). The cells in the stroma, however, still become activated and proliferate
until they have re-formed the cell network in the stroma, and then become
‘quiescent’ again (64).
Incisional wounds, however, damage the epithelium and the basement
membrane and also affect the biomechanical structure of the cornea.

As a

consequence, mitogens and morphogens either made by the epithelium and
sequestered in the basement membrane or present in tears, enter the stroma,
and cause the myofibroblastic differentiation of the keratocytes (126). Cintron
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developed a full-thickness, penetrating wound model using a 3 mm trephine on
young rabbits (127). A fibrin plug, which serves as a temporary matrix for cellular
migration, forms shortly after wounding.

Initially, the plug is covered by the

migrating epithelium. After the epithelium has covered the plug, stromal cells
invade it and within three weeks replace it by a newly secreted matrix (3).
The new matrix, however, is different than the matrix present prior to
wounding. Collagen type III expression is upregulated, and the levels of keratan
sulfate proteoglycans synthesized and their sulfation decrease; decorin and
biglycan synthesis are upregulated, while chondroitin sulfate GAG chain-size
also increases (43,86,93,100). Other fibrotic ECM components secreted by these
cells are fibronectin, laminin, perlecan and SPARC (43,93,128). These changes
in ECM components secreted during the healing phase disrupt the normal
stromal organization and, combined with a decrease in the homogeneity of the
collagen fibril diameter, are detected as corneal haze (129). The activated and
myofibroblastic cells also contribute to the detectable haze (85). Over time,
however, the fibrotic tissue is remodeled; the irregular collagen fibrils are reduced
in size and the ECM returns to a state that resembles the pre-wound state.
Consequently, the pre-wound state of the cornea is restored and the
cornea recovers its transparency (43,127).

Wounds that cut through the

basement membrane of the epithelium and into the stroma do not form an initial
fibrin plug, but they also become fibrotic as has been shown using young chick
corneas (93).
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The development of LASIK eye surgery has offered scientists the
possibility of studying the stromal wound healing response in the absence of
major epithelial disruption (95,104,113,130).

During LASIK surgery all the

stromal remodeling takes place in the actual stroma, without damaging the
basement membrane in the photo-ablated zone.

While some fibrosis is

sometimes observed, it is limited to the areas where the microkeratome cuts
through the epithelium and basement membrane (130). Just as in scrape and
incision wounds, the initial response of the keratocytes adjacent to the incision
site is to undergo apoptotic cell death and create the characteristic cell-void
space (111).

Keratocytes then become activated, proliferate and migrate to

repopulate this space without becoming myofibroblastic (111).

SPECIFIC AIMS
The work in Dr. Hassell’s laboratory has focused on the goal of identifying
the mitogens that activate keratocytes and the growth factors that will induce
keratocytes to proliferate while maintaining their normal, native phenotype.
When the research presented in this dissertation was started, keratocytes were
plated in low concentrations of platelet poor horse serum to maintain the
keratocyte phenotype, and then serum added at 10% to the medium to replicate
the phenotypical change during keratocyte activation. The cornea, however, is
avascular, and corneal neovascularization results in permanent damage to the
cornea. It is therefore unlikely that the activation of keratocytes in vivo is caused
by exposure to serum or to mitogens present in serum.
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Contrary to the

fibroblast/myofibroblast differentiation, which has been shown both in vivo and in
vitro to be modulated by TGF-β (98), the mitogens that stimulate the transition
from the ‘quiescent’ to the activated keratocyte phenotype in vivo have not yet
been identified. This keratocyte activation is the initial phase of the stromal
wound healing response, after the apoptotic event.
The first aim of this dissertation was to develop a culture medium that will
allow the study of the activated keratocyte phenotype. Based on the scrape
wound healing response model in which the basement membrane is not
damaged, we proposed the hypothesis that the corneal stroma already contains
the mitogens required for the transition from the ‘quiescent’ to the activated
keratocyte phenotype. The work described in the first paper of this dissertation
tests this hypothesis by preparing a stromal extract and compares its activity to
FBS. The biochemical and biophysical characteristics of this extract and the
response of keratocyte cultures to the extract are determined. Supplemental
data to the published manuscript are presented after the paper and further
characterize the mitogens in the stromal extract.
The second aim of this dissertation was to develop a defined culture
medium that stimulates keratocytes to grow without the loss of the keratocyte
phenotype. Keratocytes in culture are quiescent and do not proliferate. A growth
medium, that allows for keratocyte growth, without the loss of the keratocyte
phenotype, would allow a more complete characterization of the keratocyte
phenotype. In the second paper, we show that keratocytes can be grown in
defined culture medium containing insulin while maintaining high levels of ALDH
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in their cytosol, secreting keratocan and maintaining a dendritic morphology. We
also show that the proteoglycans secreted by keratocytes at low density are
degraded, and that this degradation can be prevented by the addition of growth
factors to the medium.

The cornea contains high levels of ascorbate, and

ascorbate is required for the hydroxylation of collagen. In the third paper, we
added ascorbate to the insulin-containing medium described in the second paper
and measured cell proliferation, collagen and keratan sulfate proteoglycan
expression. We find that high levels of KSPG production are dependent, in part,
upon the hydroxylation of collagen.
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SUMMARY
Fetal bovine serum has commonly been used to expand the population of
keratocytes in culture. Tissue extracts, however, have also been used to grow
other cell types. We prepared a DMEM/F12 extract of corneal stroma and
compared the growth and morphology of collagenase-isolated keratocytes
cultured in DMEM/F12, or DMEM/F12 containing either stromal extract or fetal
bovine serum. Cell proliferation was measured by

3

H-thymidine and BrdU

incorporation as well as by DNA quantitation. The extract was fractionated by gel
filtration. Cell morphology was assessed by phase contrast microscopy. Culture
in both extract and serum stimulated keratocytes to proliferate, but keratocytes
cultured in the extract grew more slowly due to a longer cell cycle and to a lower
final density because of greater sensitivity to contact inhibition. Keratocytes
cultured in serum became fibroblastic while those cultured in extract retained the
dendritic morphology of quiescent keratocytes. The stimulating factors in the
corneal extract were more sensitive to heat inactivation and of higher molecular
weight than the stimulating factors in serum. These results indicate that the
mitogenic activity in extract and serum are different and that the phenotypes
resulting from growth in serum and extract are also different. Keratocytes
cultured at low cell densities in the corneal extract may mimic keratocyte
activation, an initial and crucial event for keratocytes during the corneal wound
healing process.
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INTRODUCTION
The corneal stroma consists primarily of a uniquely transparent
extracellular matrix composed of collagen fibrils and proteoglycans (46,131). This
matrix is synthesized and deposited by keratocytes, which are interspersed
throughout the collagen scaffold. In the adult cornea, the keratocytes have a
quiescent phenotype that is characterized by a unique dendritic morphology and
a very low to non-existent rate of proliferation (64,84,132). Keratocytes form a
three-dimensional network of cells in contact with one another by their extensive
dendritic processes (58,133,134) (64). When the cornea is wounded, the injured
and damaged keratocytes as well as keratocytes flanking the wound undergo
apoptosis (64,105,113,135). Some of the viable remaining keratocytes become
activated to proliferate and migrate to the wound site (64,136,137). Keratocytes
and/or activated keratocytes can also become myofibroblasts, keratocyte
derivatives characterized by the presence of extensive α-smooth muscle (α-SM)
actin filaments (138). TGF-b has been shown to induce keratocytes to become
myofibroblasts in vitro (98) and is responsible for producing the myofibroblast
phenotype in vivo (89). Fibroblast growth factor has been shown to be
antagonistic to this phenotype (103). These observations suggest that there are
at least three different in vivo keratocyte phenotypes: quiescent, activated and
myofibroblast. Collagenase isolated keratocytes cultured in serum-free medium
do not proliferate and retain many aspects of their in vivo quiescent phenotype
(66,98,100,139) Fetal bovine serum will induce keratocytes in culture to
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proliferate but also causes keratocytes to become fibroblasts and myofibroblasts
(102).
Extracts of the EHS tumor, known as Matrigel, can induce certain cell
types to proliferate and maintain a more native phenotype in culture than that
achieved by culture in medium containing serum (140-145). The cells that
comprise the EHS tumor produce an extensive basement membrane matrix
which consists of collagen IV and laminin, and the extracts of the tumor primarily
benefit cells that make basement membranes, such as endothelial and epithelial
cells. Keratocytes are embedded in an extracellular matrix, consisting primarily of
collagen types I and V as well as leucine rich proteoglycans (46,131).
Consequently, we prepared an extract of corneal stroma to use as a culture
medium for keratocytes. The results showed that, much like serum, stromal
extract stimulated the proliferation of keratocytes, but keratocytes cultured in
extract appeared phenotypically distinct from keratocytes cultured in serum.

MATERIALS AND METHODS

Stromal extract preparation
The epithelia of twelve-month old calf corneas was removed by scraping the
corneas with a 10 rounded blade scalpel and the endothelia removed by blotting
the corneas on filter paper. The resulting corneal stromas were minced using a
razor blade and then homogenized in 5ml of DMEM-F12 per gram of wet weight
cornea for one minute on ice using a Polytron (PT3100, Kinematica). The
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homogenate was gently rocked overnight at 4ºC and the insoluble material
pelleted at 20,000 x g for 30 minutes. The homogenate was then centrifuged at
33,000 RPM for 1 hour in a Beckman 50.2 Ti Rotor. This clarified extract was
filter-sterilized using a 0.2 µm filter and stored frozen at –80°C until further use.
This was designated as 100% extract, and all further dilutions of the extract were
made with fresh DMEM/F12 prior to use.

Keratocyte isolation and culture
Bovine keratocytes were isolated and cultured as previously described (100).
Briefly, corneas were dissected from freshly harvested, 12-month old calf eyes
(Pel-Freeze Biologicals, Rogers, AR) and sequentially digested with collagenase
to specifically isolate the keratocytes. The keratocytes were plated at 10,000
cells/ cm2 (unless otherwise indicated) in DMEM/F12 (Invitrogen, Carlsbad, CA)
supplemented with 1% platelet poor horse serum (PPHS).

Plating day was

designated day zero. The medium was replaced the next day (day 1) with
DMEM/F12, DMEM/F12 containing 10% fetal bovine serum or DMEM/F12
containing 20% (unless otherwise indicated) stromal extract. The medium was
changed every 4 days.

Measurement of DNA synthesis
Culture media was supplemented with 10 µCi 3H-thymidine (NEN, Boston, MA)
per ml from day 1 to day 3. For the cell cycle analysis, the medium was
supplemented with 10 µCi

3

H-thymidine for only 3-hour time periods. The
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medium was removed and the cells lysed in 75 µl of 0.2% SDS for 10 minutes,
after which 0.375 ml of 1X TNE were added to each well and gentle rocking
continued for 10 more minutes. The cell layers were then scraped and
transferred to a 1.5 ml boil-proof Eppendorf tube. Fifty microliters of a 2 mg/ml
BSA solution and 1/10 volume of cold 100% trichloroacetic acid (TCA) were
aliquoted into each tube, the contents mixed and nucleic acids and proteins were
precipitated on ice for 1-hour or at 4°C overnight. Insoluble materials were
pelleted by centrifugation at 20,000 x g for 10 minutes, and the pellet washed
three times with cold 5% TCA. Two hundred microliters of 10% TCA was added
to each tube prior to heating samples for 30 minutes at 90ºC to hydrolyse the
DNA. The insoluble material was removed by centrifugation, and the isotope
incorporation in the supernatant was measured by liquid scintillation counting.

Molecular sieve chromatography
Five ml of either 100% stromal extract or 100% fetal bovine serum were applied
to a column (35 x 2.5 cm) containing Sephacryl S-300 equilibrated and eluted in
DMEM/F12 at 3ml/min. The serum was dialyzed against DMEM/F12 prior to
loading on the column. Nine ml fractions were collected, filter sterilized and
diluted to 10 % in DMEM/F12 for use as culture medium.
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Heat inactivation
Twenty percent dilutions of the extract in DMEM/F12 or 10% dilutions of FBS
were incubated at 50, 60, 70, 80 and 90ºC for ten minutes and then cooled in
icewater. Each aliquot was sterilized by filtration prior to heating.

DNA content
Cells were harvested at designated time-points and the DNA content measured
using a Cyquant kit (Molecular Probes, Eugene, OR) according to the
manufacturers instructions.

Micromass culture and BrdU labeling
20,000 keratocytes in 20µl of DMEM/F12 containing 1% PPHS were spotted onto
dry tissue culture plates. After cell attachment, the wells were flooded with
DMEM/F12. The medium was replaced by DMEM/F12 or DMEM/F12 containing
20% stromal extract on day 1,and then supplemented with BrdU on day 4 for 24
hours. The BrdU labeling and detection Kit 2 (Roche Diagnostics, Indianapolis,
IN) was used and the detection protocol optimized for our experiment. The cells
were photographed using a Nikon inverted microscope and a SPOT Digital
camera.
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Statistical analysis
All statistical comparisons were made using Statview Version 5 (SAS Institute,
Cary, NC). The different treatment groups were evaluated using a paired t-test.
All figures show mean± standard error when n≥4 and mean ± standard deviation
for n<4.

RESULTS

The effect of increasing concentrations of stromal extract in the medium
on 3H-thymidine incorporation by keratocytes was evaluated first. A progressive
and significant increase in 3H-thymidine incorporation was observed from 2% to
20% stromal extract to a maximum with 20% extract, with no significant
difference between 20%, 30% and 50% (Figure 1). Stimulation of 3H-thymidine
incorporation by medium containing 10% serum was similar to 20% stromal
extract. Killing the keratocytes by freezing the corneas at -80°C for 1 hour prior to
mincing and extraction did not alter the amount of extractable stimulatory activity
(Figure 2). This indicates that the DNA synthesis stimulating activity is not
derived from metabolic processes or apoptosis resulting from mincing and
homogenizing the corneal stromas.
We then determined 3H-thymidine incorporation for 3-hour segments over
a 48-hour period after the addition of DMEM/F12, DMEM/F12 containing 20%
extract and DMEM/F12 containing 10% serum (Figure 3). There were 15- to 18hour lag periods for cells cultured in serum and in extract, respectively, before
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DNA synthesis began to rise. This long lag time indicates that the keratocytes are
locked in G-0 of the cell cycle and this explains their quiescent behavior in-situ
and in culture in DMEM/F12 alone. DNA synthesis for keratocytes in extract
reached a maximum at 24 hours, declined to nearly baseline at 39 hours and
then rose again at 48 hours. In contrast, DNA synthesis for keratocytes in serum
showed maxima at 21, 36 and 42 hours with little decline in between. These
results indicate that keratocytes cultured in serum have a shorter cell cycle than
keratocytes cultured in extract.
The growth rate of keratocytes cultured over a 13-day time period was
determined by measuring the DNA content of each well (Figure 4). Keratocytes
cultured in 10% serum grew more rapidly and achieved a higher density than the
cells cultured in 20% extract. Keratocyte cultures contained 13.3 ng/well of DNA
on day 1. This value increased to 450 ng/well on day 9 for keratocytes cultured in
extract and 1028 ng/well for keratocytes cultured in serum. This indicates that
keratocytes in extract underwent five culture doublings, while keratocytes in
serum underwent six culture doublings in an eight-day period. These results
suggest that keratocytes cultured in the extract grow at a slower rate than
keratocytes cultured in serum, and this confirms the results of the previous
experiment. Keratocytes cultured in extract also appear to be contact inhibited at
a lower final density than keratocytes cultured in serum, as both cultures reach
their respective DNA maxima at day 9.
The effect of initial keratocyte plating density on the keratocytes response
to 20% extract was evaluated next. Keratocytes plated at low cell densities were
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stimulated equally by 10% serum and by the stromal extract to incorporate 3Hthymidine into DNA (Figure 5). Keratocytes plated at high density, however, were
stimulated to synthesize DNA significantly more by 10% serum than by the
stromal extract. This suggests that keratocytes cultured in the extract are more
sensitive to contact inhibition or density dependent growth than keratocytes
cultured in serum.
DNA synthesis by keratocytes cultured in 20% extract in micromass
culture was also determined by BrdU labeling (Figure 6) for a 24-hour period.
Most, if not all, of the cells in the periphery of the micromass culture spot have
incorporated BrdU into DNA, a signal that they are synthesizing DNA. However,
in the center of the spot, where keratocytes are in close contact, only a few cells
incorporate BrdU. Keratocytes cultured in DMEM/F12 alone did not stain
positively for incorporated BrdU (data not shown). These results show directly
that the extract does not stimulate the keratocytes that are in close proximity to
each other to synthesize DNA.
Using phase-contrast microscopy we analyzed the morphology of
keratocytes cultured in extract or in serum. At low density, cells in serum and
extract appeared similar three days after plating, but the cells in extract had more
prominent dendritic processes (Figure 7A and B). At confluence, the cells in
serum covered the whole plate and appeared to overlap each other (Figure 7C),
a process typical of fibroblasts. In contrast, cells cultured in stromal extract still
maintained space between cell bodies at confluence, and the cells were
connected by multiple dendritic processes (Figure 7D).
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We also evaluated the sensitivity of the stimulating factor(s) in the extract
and the serum to heat treatment. Keratocytes cultured in the heat-treated stromal
extract show a decreasing rate of 3H-thymidine incorporation proportional to the
treatment temperature (Figure 8). In contrast, a more gradual decrease in activity
is observed for heat-treated 10% serum; there is a 20% loss of proliferating
activity between 37° and 80°C treatment compared to a 64% loss for extract.
These results suggest that the mitogenic factor(s) in the extract is (are) different
than those in serum.
Both the stromal extract and fetal bovine serum were fractionated on a
molecular sieve column, and each fraction of the column was monitored for
protein content by optical density at 280 nm (Figure 9A) and for DNA synthesis
by

3

H-thymidine incorporation (Figure 9B).

The optical density profile for

fractionated serum consisted of one major peak eluting at fractions 8-13, while
the extract resolved into three major peaks at fractions 8-10, 13-14 and 18
(Figure 9A). The DNA synthesis promoting activity in the fractionated extract
eluted in one major peak at fraction 8 while the activity in serum eluted in two
peaks at fractions 9 and 12 (Figure 9B). This indicates that the mitogens in
extract have a higher molecular weight than those present in serum.
(Note to reader: these two last figures have been changed for the dissertation.
Figure 9. A. now shows the fractionated extract (activity and A280) while Figure 9.
B. now shows the fractionated serum.)
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DISCUSSION

This study shows that the corneal stroma contains a readily extractable
mitogen that can stimulate DNA synthesis and proliferation of keratocytes similar
to that produced by culture in 10% fetal bovine serum. Keratocytes in extract,
however, grew more slowly because of a longer cell cycle and were contact
inhibited at a lower cell density than keratocytes cultured in serum. At
confluence, cells in extract were separate from each other and appeared
dendritic with a large cell body and long branched cell processes, similar to that
seen for quiescent keratocytes (99). In contrast, cells in serum were in close
contact and appeared to overlap at confluence. These results suggest the cells
cultured in extract are phenotypically distinct from cells cultured in serum.
The mitogenic factor extracted from the corneal stroma is different than the
mitogenic factor(s) present in serum. First, the mitogen(s) in serum caused the
cells to cycle with a shorter frequency than the mitogen(s) present in the stroma.
Furthermore, the stromal mitogen exhibits a higher molecular weight and a
greater sensitivity to heat than the mitogen present in serum. The high molecular
weight and heat sensitivity of the mitogen isolated from the stroma suggests that
it may be a large protein, although it may be a small molecule bound to a large
protein.
The mitogenic factors in fetal bovine serum and in the stromal extract
used in this study are not known. Some of the growth promoting properties of
matrigel, an extract of the EHS tumor (145), have been shown to be due to
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certain growth factors (143) and the basement membrane protein laminin (140).
It is likely that the growth promoting activity in the stromal extract is also due to
certain growth factors and stromal matrix components and these are yet to be
identified. Even without identifying the mitogenic factors, however, the extract
will be useful for expanding the population of keratocytes in culture in a
phenotype distinct from that achieved by culture in serum.
An earlier study showed that extracts of rabbit corneas stimulated DNA
synthesis of keratocytes but only by 40-60% (146). In that study, keratocytes
were cultured in medium containing serum that would have also stimulated the
keratocytes to proliferate, therefore masking the activity of the extract.
Furthermore, the extracts were lyophilized before use and this may have
inactivated some of the factors.
We propose that the mitogens in the extract that stimulate keratocyte
proliferation in vitro may induce the activated phenotype seen during in vivo
wound healing. The keratocytes in the mature cornea would likely be in contact
with the mitogen isolated in extracts of corneal stroma since its extractability
would indicate that it is readily diffusible. These keratocytes could not respond to
the mitogen because the cell-cell connections via dendritic processes would
cause them to be contact inhibited. Once the cornea is wounded, however, the
keratocytes in the wound area as well as the keratocytes adjacent to it undergo
apoptosis, resulting in an area void of cells. It is likely that the void would create a
loss of cell-cell contacts on one side of the remaining keratocytes flanking the
void, and this loss would allow them to be activated by the diffusible mitogen
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present in the stroma. The now activated keratocytes would proliferate and
migrate into the cell void area. When they repopulated the void and reformed the
three-dimensional network of cells, they would again become contact inhibited
and cease dividing. In this proposed keratocyte activation mechanism, the
mitogen is always present and the initiating event is loss of cell-cell contact.
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Figure 1. Dose response curve of stromal extract compared to serum.
3

H-thymidine incorporation by keratocytes cultured in different levels of stromal

extract and 10% serum. Maximum DNA synthesis is seen at a 20% stromal
extract concentration. Values expressed as mean ± standard error of mean. *
indicates that the stimulation by extract (*1, p<0.0001) and serum (*2, p<0.0001)
are statistically different than culture in DMEM/F12 alone (0% extract).
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Figure 2. Effect of freezing on extract potency
Fresh corneas or corneas that had been frozen and thawed were minced,
homogenized and extracted. Freezing the corneas did not result in a significant
change in extract potency, indicating that the factor present is not a result of a
metabolic process by injured keratocytes. Values expressed as mean ± standard
error of mean, no significant difference was observed between fresh and frozen
corneas. Legend: CE 20%: corneal extract made from fresh corneas (used at
20% concentration); FCE 20%: corneal extract made from frozen corneas (used
at 20% concentration)
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Figure 3. Analysis of entry into S-phase by keratocytes cultured in serum
and in extract.
Keratocytes plated out at 10,000 cells/cm2 were cultured in 20% stromal extract
(SE) or 10% serum starting on day 1. The medium was supplemented with 10
µCi/ ml of 3H-thymidine and the cells labeled for 3-hour time periods. The cells
cultured in DMEM/F12 containing extract initiate DNA synthesis at least 3 hours
after the cells in serum. There is a decline in DNA synthesis between the cycles
in extract-cultured keratocytes, which is not as apparent in cells cultured in
medium containing serum. Values expressed as mean ± standard error of mean.
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Figure 4. Growth rates of keratocytes cultured for 12 days.
3,300 cells/ cm2 were plated in 12 well tissue culture plates and cultured in
DMEM/F12, DMEM/F12 plus 10% serum or DMEM/F12 and 20% stromal extract
(SE). The medium was aspirated and the DNA content measured.
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Figure 5. Effect of plating density on keratocyte response to stromal extract
and to 10% serum. Keratocytes were plated at the shown plating densities/cm2
on a 12 well plate, and cultured in DMEM/F12 supplemented with 20% stromal
extract (SE) or DMEM/F12 with 10% FBS. Keratocytes at low initial plating
densities incorporate 3H-thymidine at the same rate in both extract and serum.
Keratocytes at the highest density incorporate significantly more 3H-thymidine in
serum than in extract. Values expressed as mean ± standard error of mean, *
indicates that the stimulation in extract (*1, p=0.0004) or serum (*2, p=.0149) are
statistically different between high and low plating densities.
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Figure 6. Micromass culture with BrdU labeling.
Keratocytes were plated at 20,000 cells/20 µL, allowed to attach and then
cultured in medium containing 20% stromal extract. On day 4, the medium was
replaced by 20% stromal extract containing BrdU for 24 hours. The black cell
nuclei indicate cells that incorporated BrdU into DNA.
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Figure 7. Phase contrast images of keratocytes cultured in serum (FBS)
and stromal extract (SE). The cells were plated at 3,300 cells/cm2 and
photographed after 3 days (low density, LD) and then again after 10 days
(confluence, CF). A) Keratocytes at low density in serum. B) Keratocytes at low
density in stromal extract. C) Keratocytes in serum at confluence. D) Keratocytes
at confluence in stromal extract.
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Figure 8. Effect of heat on stromal extract and serum activity
DMEM/F12 supplemented with either 20% stromal extract (SE) or 10% serum
were heated and the effect of heating on the proliferating activity measured.
Keratocytes were radiolabeled with 3H-thymidine for 48 hours and incorporation
measured as previously described. The activity of the stromal extract is more
sensitive to heat than the activity of serum. Values expressed as mean ±
standard error of mean, * indicate that heat results in a statistically different
stimulation for extract (*1, p<0.0001) or serum (*2, p=0.0149) when compared to
unheated, supplemented medium.
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Figure 9. Chromatography of serum and extract on S-300. The fractions of
the S-300 column were used as culture medium for both the serum and stromal
extract runs. Keratocytes were radiolabeled for 48 hours with 3H-thymidine and
incorporation measured as previously described. Values expressed as mean ±
standard error of mean. Note to reader: this figure has been modified from the
actual published figure.
A. Mitogenic activity of stromal extract fractions and respective A280 nm
B. Mitogenic activity of serum fractions and respective A280 nm
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Figure 9
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SUPPLEMENT TO PAPER 1
SUMMARY
Paper 1 focused mainly on the mitogenic effect of the stromal extract, and
also on some of the biochemical characteristics of it. Since the publication of that
manuscript, however, significance advances have been achieved in identifying
proteins found in the stromal extract, the biochemical characteristics of the
extract and its instability in denaturing buffers (like 4M Guanidine HCl or 8 M
urea). The effect of culture in stromal extract on sulfate incorporation was also
studied. This supplement presents data not originally published, but that support
the argument that the cornea contains the mitogens required for the activation of
keratocytes in-situ and that these can be extracted in DMEM/F12. It also
presents evidence that the different keratocyte phenotypes can be induced by
using extract in culture. As the main goal of this dissertation is to develop culture
media that will allow the study of the different keratocyte phenotypes,
experimental results of importance to the matter are presented. All the methods
used in this section have been either previously described or will be described in
papers 2 and 3, therefore, only a short description of the method used will be
provided.
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LIST OF EXPERIMENTS
1. Effect of serum on mitogenic potency of growth factors
2. Sulfate stimulatory activity of BSA, size exclusion chromatography
3. Mitogenic activity of extracts made of lens, vitreous and retina
4. Sulfate incorporation by extract compared to serum
5. Keratocyte cultured in extract or extract plus TGF-B, activation and
myofibroblastic transformation
6. S-300 chromatography of extract
7. Heparin affinity chromatography
8. Antibody neutralization of stromal extract
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Traditionally, keratocytes were plated and cultured in 10% FBS. This
plating resulted in the cells becoming fibroblastic. An alternative method was
developed in which cells were plated in medium containing 1% PPHS to facilitate
cell adhesion. This medium was removed on day 1 and changed to serum-free
medium (SFM). It was found, however, that 1%PPHS did not enhance cell
binding to the culture dishes, and seemed to affect the response to growth
factors. To determine the effect of serum on growth factor potency, keratocytes
were plated in SFM or 1%PPHS-DMEM, and switched on day 1 to SFM, or
0.1%PPHS-DMEM (Supplement Figure 1) with or without growth factors or
extract. The cells were radiolabeled with 3H-thymidine for 48-hours, and
incorporation determined on a per well basis. Compared to keratocytes plated in
SFM and cultured in SFM, keratocytes plated in 1%PPHS and switched to SFM
on day 1 incorporated 84-fold more thymidine, and 140-fold more if plated and
cultured in medium containing serum. Keratocytes plated in SFM, and cultured
in medium supplemented with FGF-2, incorporated 18-fold more thymidine than
cells in SFM alone. Compared to FGF-2/SFM medium, keratocytes plated in
1%PPHS-DMEM and cultured in FGF-2/SFM incorporated 14-fold more
thymidine, and this increased to 19-fold if the cells had been plated in 1%PPHS
and cultured in FGF-2/0.1PPHS-DMEM. PDGF-BB, when used in SFM, only
increased thymidine incorporation 5-fold over SFM. When serum was used in
the plating medium, however, keratocytes cultured in PDGF-BB incorporated 40fold more thymidine than the PDGF-SFM cells, and this increased to 60-fold if
serum was present in the culture medium. Adding extract to keratocytes plated
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in SFM stimulated thymidine incorporation 280-fold over keratocytes cultured in
SFM. However, the cells plated in 1%PPHS and cultured in extract incorporated
35% more thymidine and total thymidine incorporation was unchanged if 0.1%
PPHS was present in the medium. This suggests that keratocytes isolated from
the stroma and plated in SFM do not proliferate and the small amount of
thymidine incorporated is likely limited to DNA repair. When serum is used in the
plating medium, however, some keratocytes are stimulated to enter the cell cycle
and divide. This explains the 80-fold increase in thymidine incorporation when
comparing keratocytes plated and cultured in SFM, or keratocytes plated in
1%PPHS and cultured in SFM. Keeping serum in the culture medium, even at
reduced concentrations, further increases thymidine incorporation, either by
stimulating a second round of division by some of the cells that divided
previously, or by stimulating more cells to divide in the initial round.
It is also clear that using serum in the plating and in the culture medium
enhances the cellular response to stimulation by the growth factors, even though
the exposure to serum may be temporary. It is likely that serum causes some
keratocytes to re-enter the cell cycle and some cells undergo division even after
removing of the growth factors (they are past the restriction point). This was also
detected in the cell cycle experiment in paper 1 (Figure 3). In contrast, serum at
plating appears to stimulate most cells cultured in the presence of growth factors
to enter the cell cycle as evidenced by the large increase in thymidine
incorporation (similar to the incorporation of extract in SFM). Paper 1 shows that
all of the cells in extract are dividing and that the cell cycle takes around 30
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hours. Incorporation by cells in extract starts after 15 hours, and declines after
around 39 hours only to rise again between 45 and 48 hours. If all the cells in
extract enter the cell cycle at 15 hours, then the most likely explanation to why
keratocytes in extract incorporated more thymidine when plated in medium
containing 1%PPHS compared to SFM is that the presence of PPHS at plating is
causing the cells to re-enter the cell cycle faster. These cells, however, do not
advance into S-phase in the absence of growth factors. Serum removal is a
method commonly used to synchronize cells in cell cycle studies, and it has been
shown that expression of growth factor receptors increases after removal of
serum. It is therefore also possible, that the keratocytes plated or cultured in
serum express receptors for FGF-2 and PDGF-BB after serum removal, and that
the addition of these growth factors to the medium allows the cells to then enter
S-phase and divide.
These results show that the addition of serum to the medium at plating, or
adding serum to the culture medium, affects the response of the keratocytes to
the growth factors, although, in the absence of growth factors, it does not affect
the cellular morphology.
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Figure 1. Effect of serum on mitogenic potency of growth factors
Keratocytes were plated in serum-free medium, or in DMEM/F12 supplemented
with 1%PPHS. On day 1, the culture medium was changed to SFM or
DMEM/F12 supplemented with 0.1% PPHS and the treatment with growth factors
started.
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The mitogenic activity of the extract was lost when 4 M guanidine was
used as buffer for gel filtration chromatography. The stimulation of sulfate
incorporation by the denatured extract, however, was not affected. The factor
that stimulated sulfate incorporation was identified after purification by gel
filtration and its sequence matched bovine serum albumin (BSA). In the second
experiment, BSA at increasing concentrations was added to the culture medium,
and its effect on sulfate incorporation by keratocytes plated at low and high
density measured (Supplement Figure 2 A). The addition of BSA at 0.01mg/ml
or 0.1 mg/ml increased sulfate incorporation 8-fold by keratocytes plated at either
plating density. Only a BSA concentration of 1mg/ml increased sulfate
incorporation 10-fold for keratocytes at low density and high density. Culture in
10% extract stimulated sulfate incorporation 8-fold, similar to BSA at 0.01 or 0.1
mg/ml.
Equivalent counts of incorporated sulfate by cells plated at low and high
density, and cultured in SFM, or medium containing BSA or 10% extract, were
separated using Superose 6 to determine if the incorporation under these culture
conditions was into full-length proteoglycans or into GAG side-chains only
(Supplement figure 2 B and C). The chromatograms of incorporated sulfate of
cells cultured in BSA and extract show that extract stimulated sulfate
incorporation slightly more than BSA, and the peaks containing full-length CS
and KS proteoglycans are detected (2B and C, fractions 15-23). Keratocytes at
low density (2B), as also shown in paper 2 figure 6, degraded most of the
synthesized proteoglycans, and the GAG chains are detected between fractions
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27-32. At high plating density, the elution profile of the synthesized
proteoglycans in the presence of BSA or extract is identical to the elution profile
of the synthesized proteoglycans at low plating density under those culture
conditions. The incorporation profile of keratocytes cultured in SFM, however, is
different. At high density, most of the incorporated sulfate elutes between
fractions 16 and 23, the size of the full-length proteoglycans, the peak in fractions
25-28 is most likely PGDS, made by keratocytes in culture as a KSPG.
These results suggest that BSA increases proteoglycan synthesis as well
as the accumulation in the medium. BSA may also enhance the uptake of
radiolabeled sulfate from the medium, resulting in increased incorporation into
the proteoglycans. However, it is also possible that BSA stabilizes the
proteoglycans in solution, preventing their degradation in culture, or due to the
high concentration of BSA used in the study, that the BSA is shielding the
synthesized proteins from degradation. The nature of the extract also suggests
that it contains ECM components of the corneal stroma, similar to the ones being
synthesized and secreted by the keratocytes. These proteins should, in a
manner similar to the added BSA, shield the newly synthesized proteoglycans
from degradation. The extract also contains BSA, so it is conceivable that the
BSA in the stromal extract may also stabilize the proteoglycans synthesized in
culture, so that the increase in sulfate incorporation detected is the base rate of
proteolgycan synthesis by keratocytes, but instead of being degraded these
proteoglycans are allowed to accumulate in the medium.
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Figure 2. Stimulation of sulfate incorporation by BSA. (A) Effect of BSA on
sulfate incorporation by keratocytes at low and high plating density compared to
incorporation in extract. (B) and (C) Chromatogram of medium of cells cultured
in extract, BSA or SFM at low (B) and high (C) plating densities.
A.
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Figure 2 B and C. Superose 6 chromatograpy of incorporated sulfate.
Keratocytes were plated at low (5,000 cells/cm2)(B) and high density (20,000
cells/cm2)(C) and cultured in medium containing 0.1mg/ml BSA or 10% stromal
extract
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Paper 1 describes that the corneal stroma contains mitogens that
stimulate keratocytes to proliferate in a dose and cell density-dependent manner.
In the third experiment, extracts from lens, retina and vitreous from bovine eyes
were made and tested on keratocytes to determine if these other parts of the eye
also stimulated thymidine incorporation (Supplement Figure 3). Of the extracts
made, only lens extract stimulated thymidine incorporation by keratocytes. The
lens is bathed by the aqueous humor, which also bathes the corneal
endothelium. It may be possible that the mitogens responsible for activity in the
stroma may also be present in the lens extract, but not in other parts of the eye.
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Figure 3. Mitogenic activity of extracts made from lens, vitreous and retina.
For retina and lens, the extract preparation was identical to the preparation of the
stromal extract. Tissues were extracted in 10 volumes of DMEM/F12 overnight
at 4 C, and the insoluble materials precipitated by centrifugation. Due to its high
volume, the vitreous was extracted in 2 volumes of DMEM/F12 overnight.
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Activated keratocytes, during wound healing, predominantly synthesize
chondroitin sulfate proteoglycans and less keratan sulfate proteoglycans (43,93).
In culture, this is replicated by adding fetal bovine serum to the culture medium
(99,100). If the mitogens in the extract are responsible for the activation of
keratocytes, a decrease in keratan sulfate would be expected, and a relative
increase in chondroitin sulfate. To test this, keratocytes were cultured in SFM, or
SFM containing 20% extract or 10% FBS (Supplement Figure 4) and both total
sulfate incorporation, as well as GAG sidechain composition were analyzed and
compared. Keratocytes cultured in extract or FBS incorporated 11-fold or 20-fold
more sulfate into GAGs than keratocytes in SFM, respectively. 20% of these
GAGs were sensitive to endo-b-galactosidase (EBG) digestion, indicating that
20% of the GAGs made in extract are keratan sulfate, a significant decrease
compared to the 40-60%KS synthesized by quiescent keratocytes. In contrast,
over 94% of the proteoglycans synthesized by cells cultured in FBS were
sensitive to chondroitinase ABC, and only 5% to EBG. These results suggest
that keratocytes cultured in extract, besides proliferating, also secrete ECM
components that are different to the ECM components of the in-situ, quiescent
keratocytes and are similar to the ECM components detected during wound
healing. This evidence further suggests that the mitogens present in the extract
are responsible for the activation of keratocytes during the wound healing
response.
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Figure 4. Sulfate incorporation stimulated by extract compared to serum.
A. Sulfate incorporation by keratocytes cultured in extract or serum.
B. type of GAG parent of the incorporated sulfate. Keratocytes in SFM
incorporate equal amounts of sulfate into both CS or KS.

A

B
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Keratocytes activated during the wound healing response become
myofibroblastic when exposed to TGF-β released from the damaged basement
membrane (126). In culture, the activation is usually replicated by the addition of
serum to the culture medium, and the myofibroblastic transformation by the
addition of TGF-β (98). Recent evidence suggests that TGF-β is sufficient to
cause the myofibroblastic differentiation of the cells, but that it requires PGDF-BB
and integrin signaling (91). Keratocytes are also activated when cultured in
extract, and in this experiment TGF-β was added to the culture medium
containing extract to determine if keratocytes cultured in extract and TGF-β also
transformed into the myofibroblast phenotype (Supplement Figure 5).
Consequently, TGF-β (5ng/ml) was added to keratocytes cultured in 10% extract.
The cells were photographed after 4 days, before the cell layer was dissolved in
2%SDS for Western blot analysis (Supplement Figure 5 A). Keratocytes cultured
in extract maintain the characteristic dendritic morphology, but flatten, lose their
dendritic morphology and grow to cover the culture dish when TGF-β is added.
The medium of cells cultured in SFM (negative control), cells cultured in FBS
plus TGF-β (positive control), cells cultured in extract and extract plus TGF-β was
immunoblotted (Supplement Figure 5 B) against fibronectin and SPARC, and the
cell layer for aSMA. A water extract of the cytosol was stained for total protein,
to detect the presence of the ALDH band (fourth row, arrow). Perlecan was
detected by immunoprecipitation. Keratocytes cultured in SFM or extract alone
do not make perlecan, SPARC or fibronectin or contain aSMA at either day 4 or
day 8. The ALDH band in keratocytes cultured in extract or extract plus TGF-β,
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however, decreases considerably by day 4 and is only faint in the day 8 stromal
extract cultures. No band was detected in the cells cultured in extract plus TGFβ. Keratocytes cultured in extract plus TGF-β, however, are positive for all
fibrotic markers. A weak signal is detected at day 4, but the signals are very
strong at day 8.
These data suggests that the mitogens in the extract activate keratocytes
to proliferate, but do not cause them to become myofibroblastic and express
markers for that phenotype. It is likely that keratocytes respond to TGF-β
stimulation by inducing PDGF expression, but that this transformation is slow.
PDGF, however, is present in serum, so the fibroblast-myofibroblast phenotype
change occurs in less time than in cultures without extraneous PDGF (like
extract, or SFM + TGF-β). Taking the data from Supplement Figure 4 and Figure
5 together indicate that culture in extract only results in the activation of the
keratocytes, but not in a myofibroblastic transformation unless TGF-β is present
in the culture medium. When extract and TGF-β are used, the cells become
myofibroblastic, and express the markers for that phenotype.
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Figure 5. Effect of TGF-β on keratocyte cultures. (A). Cell morphology of cells
cultured in extract (A) or extract with TGF-β (B). (B.) Western blots of the
medium of day 1, day 4 and day 8 cultures for SPARC, fibronectin and the cell
layer for aSMA. Total water-soluble cytosolic proteins stained with Coomassie
for ALDH (arrow).
D, DMEM/F12 (control); SE, stromal extract 10%; SET, 10% Stromal extract
5ng/ml TGF-β; FT, 10% FBS 5ng/ml TGF-β (positive control). Prestained
molecular weight markers are indicated at the margin.

A. extract

B. extract plus TGF-β
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Figure 5 B. Western blots to fibronectin, SPARC and aSMA.
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The mitogenic activity in the extract eluted in the high molecular mass
range when fractionated using S300 gel filtration chromatography (paper 1, figure
7) and low salt buffers, suggesting that the mitogens found in extract are either of
very large size, or that they are part of a large complex. In order to isolate or
identify the components of the complex, strong denaturing solvents, such as 4M
guanidine HCl or 8 M urea, are commonly used. The use of these solvents,
however, resulted in the loss of most of the mitogenic activity and could not be
recovered after extensive dialysis against water or by dialysis of guanidine
exposed extract against water (data not shown). Consequently, as an
alternative, less stringent buffers were used to fractionate the extract(Supplement
Figure 6 A and B). The elution profiles of the mitogenic activity using low and
high NaCl concentrations under non-denaturing and mild denaturing conditions
are shown in Supplement Figure 6A and B. Extract was dialyzed against water,
concentrated 10-fold and its NaCl content adjusted to 0.15 or 2M NaCl (A) prior
to fractionation on an S300 column equilibrated and eluted in buffer containing
the same salt concentration. The fractions were then dialyzed against DI water,
diluted with the same volume of 2X DMEM/F12 and sterilized by filtration prior to
their use in cell culture. Thymidine incorporation was measured as described in
paper 1. The narrow peak (2 fractions) containing mitogenic activity detected at
physiological salt concentrations broadens considerably at 2M NaCl (A) (to 4
fractions), suggesting that the mitogenic activity is part of a complex held
together at least partially by charge-charge interactions. When the experiment
was repeated, but the extract fractionated in buffer containing 1M Urea, 1 mM
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CHAPS and varying concentrations of NaCl (B) (0.15M, 1M and 2M,
respectively) the mitogenic activity eluted as a broader peak in low salt (solid
line). Increasing the NaCl concentration to 1M narrowed the elution profile of the
mitogen peak, and a distinct, second peak formed at fraction 8. When separated
using buffer containing 2M NaCl, the mitogenic activity eluted in two distinct,
narrow peaks. This further suggests that the mitogenic activity of the extract is
part of a protein-protein complex, and not due to one large protein. Taken
together, these data suggest that the extract contains a complex that has
mitogenic activity, that is held together by both charge-charge and protein-protein
interactions.
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Figure 6. Gel filtration chromatography. (a) S-300 chromatography of extract
in low or high NaCl (A) or under dissociating conditions (B). (A) Extract was
concentrated 10-fold and separated on S-300 in running buffer containing low
(0.15M, solid line) or high (2M, dashed line) NaCl. (B) Concentrated extract was
separated on the same column at increasing NaCl concentrations in the
presence of 1mM CHAPS and 1M urea.
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Figure 6. Gel filtration chromatography. (a) S-300 chromatography of extract
in low or high NaCl (A) or under dissociating conditions (B). (A) Extract was
concentrated 10-fold and separated on S-300 in running buffer containing low
(0.15M, solid line) or high (2M, dashed line) NaCl. (B) Concentrated extract was
separated on the same column at increasing NaCl concentrations in the
presence of 1mM CHAPS and 1M urea.
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Heparin affinity chromatography has been used to purify growth factors
from serum and also tissues (147-152). Heparin is negatively charged, so
interactions with this matrix are based on charge. To test if heparin affinity could
be used to isolate the mitogen in the extract, 2 ml of extract was fractionated on 1
ml of heparin sepharose (Supplement Figure 7). The unbound material was
collected in the pass-through (PT). The resin was washed with 5 volumes of
PBS (5ml total). The bound proteins were eluted with 2ml of 0.5M NaCl (low salt,
LS) and 2 ml of 2M NaCl (high salt, HS). The mitogenic activity of these fractions
were tested either alone or combined and compared to extract alone. Most of
the mitogenic activity did not bind to the resin, and was detected in the PT.
Some activity bound to the matrix and eluted in the LS and in the HS washes.
When these two fractions were combined, however, a 7-fold increase in
thymidine incorporation over the HS eluate, and 20-fold over the LS eluate was
measured, suggesting a synergistic increase on activity. A synergistic increase
in thymidine incorporation was detected when the LS and the HS fractions were
combined. Combining the LS and the PT did not increase the activity of the PT
alone, but when all three fractions were combined the mitogenic activity
increased to twice the activity of the PT alone (or PT+LS). These results suggest
that the mitogenic activity is dependent on components of the complex present in
all three fractions and that the loss of either component results in a loss of
potency.
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Figure 7. Heparin affinity chromatography of 100% extract. Undiluted extract
was fractionated using heparin into unbound (passthrough), 0.5M and 2M NaCl
fractions (LS and HS, respectively). The mitogenic activity of the fractions was
measured alone or combined with other fractions.
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In the last experiment of the supplement (Supplement Figure 8), bovine
growth factors found in serum (FGF-2, PDGF-BB and IGF-1) and their
neutralizing antibodies were purchased and tested to determine if these growth
factors were part of the active complex in the stromal extract. To test this, SFM
was supplemented either with growth factor, antibody or extract alone, or with
growth factors plus their respective antibody or extract plus antibody, vortexed
and incubated for 1 hour at 37C and then used as culture medium for keratocytes
plated at low density. All the growth factors stimulated thymidine incorporation,
and their activity was significantly reduced when co-incubated with their
neutralizing antibodies. The presence of these antibodies, however, did not
reduce the stimulatory activity of extract. Western blots of extract to these
growth factors also failed to detect them, and no insulin was detected either.
These results suggest that the mitogenic activity in the stromal extract is not due
to any of these four growth factors.
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Figure 8. Antibody neutralization of stromal extract.
Growth factors and their respective neutralizing antibodies were obtained.
Culture medium alone, or medium supplemented with growth factors or extract
were incubated for 1 hour at 37 C with or without the neutralizing antibodies at
the concentrations recommended by the manufacturer. The antibodies
neutralized the activity of the purified growth factors, but not the mitogenic activity
of extract.
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SUMMARY
Keratocytes normally express high levels of aldehyde dehydrogenase and
keratocan. They proliferate and lose their keratocyte markers when they become
fibroblastic during corneal wound-healing. Keratocytes cultured in fetal bovine
serum also become fibroblastic, proliferate and lose these markers.

In this

report, we studied the effects of three serum growth factors, FGF-2, insulin and
PDGF-BB, on keratocyte proliferation and the maintenance of the keratocyte
markers in 7-day cultures in cells plated at low (5,000 cells/cm2) and high
(20,000cells/cm2) density in serum free medium. Keratocyte proliferation was
measured by 3H-thymidine incorporation and by DNA content of the cultures.
Cytosolic aldehyde dehydrogenase and keratocan accumulated in the medium
were quantified by Western blot.

The results showed all the growth factors

stimulated proliferation but insulin stimulated proliferation more consistently. The
keratocyte markers ALDH and keratocan were maintained after 7 days in culture
in all growth factors, but keratocyte cell morphology was only maintained in
medium containing insulin. Most of the proteoglycans were degraded in cultures
of keratocytes plated at low density and cultured in the absence of growth
factors. This degradation was prevented when keratocytes were cultured in the
presence of the growth factors or when keratocytes were plated at high density.
The results of this study show that insulin can expand keratocytes in vitro,
maintain their phenotype and prevent proteoglycan degradation.
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INTRODUCTION
Keratocytes, the cells of the mature corneal stroma, have a dendritic
morphology and are responsible for the maintenance of the extracellular matrix of
the stroma. These cells produce lumican and keratocan, two keratan sulfate
proteoglycans (41,42) that are necessary to maintain the transparency and
shape of the stroma. Lumican and keratocan are members of the SLRP family
and are the most abundant keratan sulfate proteoglycans in the corneal stroma
(153). Lumican is also present in many tissues (41) as a glycosylated protein.
Keratocan is exclusively found as a proteoglycan in the cornea (41,154). Both
keratocan and lumican (5,50,153) interact with collagen fibrils and modulate their
size and spacing (5,25,153,155).

The collagen fibrils of both lumican

(5,153,155,156) and keratocan (153,157) knock-out mice are larger and less
densely packaged than the collagen heterofibrils in the normal stroma, and in the
lumican null mouse the corneas lose transparency (153,155). The corneas in the
keratocan null mouse were reduced in thickness, most likely due to reduced
hydration of the corneal stroma. Mutations in the human keratocan gene have
been identified as a cause of cornea plana (157-159).

This suggests that

keratocan plays a fundamental role in maintenance of the corneal structure and
that its function cannot be rescued by other members of the SLRP family (160).
Keratocytes normally exhibit a dendritic morphology, but become
fibroblastic in appearance during wound healing. Both keratan sulfate synthesis
and the expression of keratocan substantially decrease during the fibroblast/
myofibroblast transformation that occurs during wound healing (43,129,161).
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Keratocytes isolated from the stroma and cultured in serum free medium retain a
dendritic morphology, and maintain the expression of ALDH and keratocan after
extended period in culture (86,100,161,162).

However, when the medium is

supplemented with fetal bovine serum the keratocytes exhibit fibroblastic or
myofibroblastic phenotypes (86,99).

Keratan sulfate synthesis and keratocan

expression decrease (163) in a manner reminiscent of in vivo wound healing
(161). This indicates that keratocan can be considered a marker for the native
keratocyte phenotype (100).
Keratocytes contain unusually large amounts of corneal crystallins such as
aldehyde dehydrogenase (ALDH) (86,88,100).

It has been speculated that

crystallins may play a role in matching the refractive index of the intracellular
space to the refractive index of the stroma (88), or they may help organize the
intracellular space and thus reduce keratocyte reflectivity (85). ALDH may also
protect the cornea from UV irradiation (164). Corneal crystallin levels decrease
markedly in wound-healing keratocytes in vivo, and this would partially explain
the increased haziness observed during the healing of corneal wounds
(86,88,100). ALDH is a 52 kDa protein and is lost from the cytoplasm during
culture in serum (100). This indicates that a high level of cytosolic ALDH is also
a marker of the native keratocyte phenotype.
The loss of keratocan and ALDH by keratocytes in culture is likely due to
factors in serum that cause changes in the keratocyte phenotype. Serum is a
complex mixture of salts, proteins, lipids, growth factors and hormones.
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One of the growth factors in serum is PDGF-BB (165), which is released
from the platelets during the clotting process (166). Removal of the platelets from
blood prior to the clotting process produces serum with substantially less growthpromoting properties (167).

In keratocyte cultures, inclusion of PDGF-BB in

culture medium causes cell migration and proliferation, as well as collagen gel
contraction and fibroblastic differentiation (162). Insulin is also present in serum
(168). Insulin interacts with its receptor and modulates metabolic processes but
also acts as a mitogen for some cell types (169,170). Studies have shown that
insulin receptors are present in the anterior segment of the eye, and insulin has
been identified as a component of tear film (171). Patients with type I and II
diabetes mellitus have abnormal changes occur at the anterior segment of the
eye (172).

Patients with diabetes show a thickening of the corneal stroma

(172,173) due to accumulation of water and elevated stromal mRNA and protein
levels of MMP3 and MMP 10 (stromelysin-1 and 2, respectively) (173-175). Fetal
bovine serum also contains FGF-2 (176,177), and FGF-2 has been shown to
promote keratocyte proliferation as well as keratan sulfate proteoglycan secretion
into the medium when cells were cultured in 0.1% platelet poor horse serum
(178).

Here we characterize the effects of FGF-2, insulin and PDGF-BB in

defined cell culture medium on keratocyte proliferation and morphology as well
as on keratan sulfate synthesis and ALDH expression, two known markers of the
native keratocyte phenotype.

We find that all growth factors caused cell

proliferation and maintained keratocan and ALDH expression, but only insulin
maintained the dendritic morphology of keratocytes. The results of this study
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suggest that insulin may play a role in the maintenance of the corneal stroma
after wounding.

MATERIALS AND METHODS
Chemicals
Chemicals were from Sigma-Aldrich (St. Louis, MO) unless otherwise indicated.

Cell Culture
Bovine keratocytes were isolated using two sequential collagenase digestions as
previously described (139,179).

Briefly, corneas were obtained from freshly

harvested, 12-18 month-old calf eyes (Pel-Freez, Rogers, AR).

The central

portion of the cornea was minced and digested with 3.3 mg/ml Sigmablend
Collagenase Type L at 37ºC under shaking for 45 min to remove the epithelium
and the endothelium.

The remaining stromal fragments were further digested

with fresh collagenase for an additional 150 min to disrupt the matrix and release
the keratocytes. The cells were pelleted by low-speed centrifugation (400 x g for
10 min) and resuspended in DMEM/F12 (Gibco, Invitrogen, Carlsbad, CA). Cell
viability and number were determined using trypan blue exclusion. The cells
were then plated in serum-free DMEM/F12 into 6-well plates (Costar, Cambridge,
MA) at low density (5,000 cells/cm2) or high density (20,000 cells/cm2) and
allowed to attach overnight at 37ºC in 5% CO2.

The medium was changed the

next day and every third day afterwards with fresh DMEM/F12 or DMEM/F12
supplemented with FGF-2 (10 ng/ml), insulin (10 µg/ml), PDGF-BB (50 ng/ml) or
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ITS [(Invitrogen, Carlsbad, CA; contains insulin (10 µg/ml), transferrin (5.5 µg/ml)
and selenium 0.67µg/ml)]. FGF-2 and PDGF-BB were used at concentrations
previously shown to stimulate maximum or near maximum proliferation of
keratocytes (162). The FGF-2 and PDGF-BB were dissolved in 1 mg/ml bovine
serum albumin (BSA) as per the manufacturer’s instructions that resulted in a
final concentration 400 and 1000 ng of BSA/ml medium, respectively.

The

presence of these low levels of BSA in the medium did not result in an increase
in DNA content, ALDH,

keratocan levels or

35

SO4 incorporation into

proteoglycans (data not shown).

35

SO4 incorporation into proteoglycans

Cultures were supplemented with 50 µCi/ml of 35SO4 (NEN, PerkinElmer, Boston,
MA) on day 1 for 72 hours and the medium was collected, frozen and lyophilized.
The dry medium was then reconstituted in 4M GuHCl and unincorporated

35

SO4

was removed using PD10 columns (Amersham Biosciences, Piscataway, NJ).
The fractions containing incorporated

35

SO4 were combined, concentrated using

Amicon Ultra spin-concentrators (Millipore Corp., Millford, MA) and fractionated
using a Superose 6 12/30 HR column (Amersham Biosciences, Piscataway, NJ)
equilibrated and eluted with 4M GuHCl containing 0.05M sodium acetate, pH 6.5
at a flow rate of 0.3 ml/min. Fractions (0.6 ml) were collected and incorporation
measured by liquid scintillation counting.
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DNA quantitation and 3H-thymidine incorporation
Cell cultures were labeled with 20 (Ci/ml of 3H-thymidine (NEN, PerkinElmer,
Boston, MA) for 72h periods on days 1 and 4. The cell layers were harvested on
days 1, 4 and 7 to measure DNA content and 3H-thymidine incorporation. Briefly,
the cell layers were rinsed with PBS, frozen, thawed and then solubilized in a
lysis buffer supplemented with a DNA binding dye (Cyquant, Molecular Probes,
Invitrogen, Carlsbad, CA). Three aliquots from each well were used to determine
the DNA content/well using fluorimetry at 480/535 nm. 3H-thymidine incorporation
was determined by precipitating an aliquot of the solubilized cells overnight at
4ºC in 10% trichloroacetic acid using BSA as a carrier protein. The precipitated
DNA was collected onto glass fiber prefilters (Millipore Cat. No. APFC02500) by
vacuum filtration. The filters were washed three times with 5 ml ice-cold 5%
TCA, placed into vials and incorporation measured by liquid scintillation counting.

Immunoblotting
Cell layers were solubilized in 2% SDS and examined for ALDH levels by SDSPAGE Western blot. The medium was collected, dialyzed and lyophilized. The
powder was reconstituted in 1/150th the volume for medium from keratocytes at
low density, or in 1/50th the volume for medium from keratocytes at high density
in water. Medium equivalent to 3 wells was for keratocytes at low density and
equivalent to half a well for keratocytes at high density were digested with endoβ-galactosidase (Seikagaku, Associates of Cape Cod, E. Falmouth, MA) and
keratocan core protein levels determined by SDS-PAGE Western blot.
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The

proteins were loaded and separated in 4-10% bis-tris gels (Novex, Invitrogen,
Carlsbad, CA). The separated proteins were electrotransferred to nitrocellulose
membranes (Bio-Rad, Hercules, CA) at room temperature, blocked with 0.2% IBlock and 0.3% Tween-20 in PBS (0.2% I-PBS-T), and incubated overnight at
4ºC with either 1:5000 anti-ALDH antibody or 1:1000 rabbit anti-bovine
keratocan. Rabbit polyclonal antiserum to bovine ALDH was a generous gift of
Dr. R. Lindahl (University of South Dakota) and the rabbit antiserum to bovine
keratocan was previously described (139). Membranes were rinsed in 0.1% IPBS-T, incubated at room temperature for 1 hour in 1:10,000 horseradish
peroxidase-conjugated goat anti-rabbit IgG (Amersham Biosciences, Piscataway,
NJ), and rinsed four times with 0.1% I-PBS-T. Protein bands were visualized
using chemiluminescence (ECL Western Blotting Analysis system; Amersham
Biosciences) on Kodak Bio-Max XAR X-ray film. Films were scanned and band
density was measured using a Bio-Rad GS-710 Calibrated Imaging Densitometer
(Bio-Rad, Hercules, CA). The resulting pixel density was divided by the DNA
content of the culture and expressed in pixel density per µg DNA.

Cell Morphology
Cell morphology was studied with a Nikon Diaphot phase contrast microscope
and recorded using a Nikon D100 digital camera. Images were resized using
Adobe Photoshop and image levels and contrast adjusted after the images were
converted to grayscale.

87

Statistical Analysis
Statistical analysis was performed using Statview (SAS Institute, Cary, NC).
Samples were analyzed using a paired t-test. Standard error was used when
n>3 and standard deviation used when n=3.

RESULTS
Keratocytes plated at low density were radiolabeled with 3H-thymidine
from days 1-4 and days 4-7 to determine the effect of growth factors on DNA.
Keratocytes cultured in all tested growth factors showed a significant increase in
3

H-thymidine incorporation during both labeling periods (Figure 1) when

compared to control. FGF-2 and PDGF-BB, however, stimulated significantly
more incorporation during the second time period than during the first time
period.
The DNA content of the cultures was measured on days 4 and 7 to
determine if the number of cells in the culture increased. By day 7, the DNA
content per well of cells cultured in ITS and insulin increased 3.1-fold, and cells in
PDGF-BB increased 2.3-fold, while culture in FGF-2 resulted in a 36% increase
while the control cultures had a 20% increase (Figure 2A). The DNA content of
cultures plated at high density (Figure 2B) also increased over the 7-day study
period, but the maximum increase in DNA content was 59% for cells cultured in
insulin, followed by ITS, FGF-2 and PDGF-BB (52%, 47% and 27% respectively),
but the DNA levels of the control cultures declined by 31%. The lower growth
rate of the cells plated at high density is likely due to contact inhibition.
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ALDH is a 52 kDa cytoplasmic protein detected in Western blots of cell
layer extracts (Figure 3, Lane 1). The pixel-densities of this protein in each
culture condition were determined and expressed per µg DNA of the cultures.
Keratocytes plated at high density and cultured for 7 days contained 1.8- times
more ALDH per µg of DNA than keratocytes seeded at low density (Figure 4).
The levels of ALDH in keratocytes plated at low density and cultured in the
presence of growth factors was not significantly different than the levels in the
control cultures (Figure 4A, open bars) but was slightly reduced at high density
(Figure 4A, filled bars). Keratocytes plated at high density and cultured in the
presence of FGF-2 contained significantly lower ALDH levels than the control
keratocytes.
Keratocytes in culture normally do not accumulate an extracellular matrix
associated with the cells but secrete proteoglycans into the medium instead
(86,99). The keratocan in the medium appears in a Western blot as a smear of
around 80-160 kDa (Figure 3, Lane 2). Digestion of the medium with endo-βgalactosidase degrades the keratan sulfate chains and shifts the smear to a
single band at 51 kDa (Figure 3, Lane 3). The pixel densities of the 51 kDa core
protein for each culture condition were determined and expressed per µg of DNA
(Figure 4B). Keratocytes at low density and cultured in FGF-2, insulin, ITS and
PDGF-BB had higher (4-, 8-, 4- and 2-fold, respectively) keratocan levels in the
medium by day 7 (Figure 4B, open bars). Keratocytes at high density
accumulated 60–fold more keratocan in the medium than keratocytes plated at
low density. Furthermore, in contrast to low-density cultures, the growth factors
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did not significantly change keratocan levels in the medium (Figure 4B, filled
bars).
The

35

SO4-radiolabeled

proteoglycans

collected

on

day

4

fractionated according to size on a Superose 6 column. The incorporated

were
35

SO4

from keratocytes plated at low density and cultured in FGF-2, insulin, ITS and
PDGF-BB eluted between fractions 16 and 23 (Figure 5A), close to the elution
positions for keratocan and decorin (fractions 17-21) as determined by
immunodot blot (data not shown).

Most of the incorporated

35

SO4 from

keratocytes cultured at low density in DMEM alone, however, eluted between
fractions 26 and 32. This is similar to the elution position for prostaglandin D
synthase (PGDS) (fractions 28-30) as determined by immunodot blot (not shown)
and the elution position of corneal keratan sulfate chains. Papain digestion did
not alter the elution position suggesting that the incorporated

35

SO4 from the

keratocytes cultured in DMEM/F12 were not bound to a large core protein (not
shown). When keratocytes were plated at high density, however, most of their
35

SO4 incorporated products eluted between fractions 17 and 22 (Figure 5B)

whether or not the cells were cultured in growth factors.
Phase-contrast microscopy was used to examine the morphology of the
cultured cells prior to harvesting on day 7 (Figure 6). Cells in DMEM/F12 retain
the characteristic dendritic morphology of in-situ keratocytes (Panel A). Cells
cultured in FGF-2, however, appear fibroblastic, with flattened, spindle-shaped
cell bodies and lack the dendritic processes (panel B) characteristic of
keratocytes. Cells cultured in insulin and ITS appear flattened but still retain their
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dendritic processes (Panel C and D respectively), yet the dendrites of cells
cultured in ITS appear longer join with other cells. Cells cultured in PDGF-BB
appear fibroblastic, have flat cell bodies and are spindle-shaped (Panel E).

DISCUSSION
The results of this study show that all the growth factors tested stimulated
3

H-thymidine incorporation and increased the DNA content of the cultures over

the 6-day culture period. Comparing the response to each of the different growth
factors, however, showed that only insulin stimulated thymidine incorporation
similarly during the first 3-day and the second 3-day time period. Furthermore,
only the cultures in insulin consistently increased in DNA content during the 6day culture period and attained the highest DNA content at the end of the 6-day
culture period for both low and high initial plating densities.

Even with this

extensive proliferation over the 6-day time period, keratocytes in insulin
maintained ALDH content and keratocan production, the two markers of the
keratocyte phenotype, as well as their dendritic morphology.

These results

suggest that insulin may be useful in expanding a population of keratocytes in
culture without changing their phenotype.
Keratocytes cultured in FGF-2 and PDGF-BB also showed increased
incorporation of 3H-thymidine in keratocytes plated at low density. The rate of
incorporation, however, was significantly higher during the second 3 day time
period than during the first time period but the DNA content of the cultures did not
increase from day 4 to day 7. This suggests that in addition to increased cell
91

proliferation, FGF-2 and PDGF-BB may also be causing cell death. Like culture
in insulin, ALDH and keratocan production were maintained by culture in FGF-2
and PDGF-BB. Unlike insulin, however, culture in FGF-2 and PDGF-BB caused
the keratocytes to become spindle shaped or fibroblastic. This suggests that cell
morphology and ALDH/keratocan production are not linked.

Overall, these

results would suggest that the loss of ALDH and keratocan by keratocytes
cultured in medium containing fetal bovine serum (88,99,100,180) is due to
factors other than the insulin, FGF-2 and PDGF-BB present in the serum.
The results of this study also show that plating keratocytes at low density
and in the absence of growth factors results in the degradation of the
proteoglycans secreted into the medium.

The incorporated

35

SO4 from

keratocytes at low density and in the absence of growth factors eluted between
fractions 27 and 32, close or with the elution position of PGDS (fractions 28-30),
a 29 kDa product (139).

In contrast, the

35

SO4 incorporated by keratocytes

cultured with growth factors eluted in one major peak between fractions 17 and
21, in the elution position of keratocan (fractions 18-20) and decorin (fractions
17-21). Keratocan and decorin are members of the small leucine rich protein
family. These proteins contain multiple leucine rich repeats whose interaction
results in the protein acquiring a horseshoe shaped tertiary structure. Keratocan,
a 50 kDa protein, has 5 N-linked glycosylation sites, but only contains 3 keratan
sulfate chains of ~14 kDa (181). Decorin, a 40 kDa protein, has one O-linked
glycosylation site that contains the chondroitin sulfate chain (182).
density, most of the

35

At high

SO4 incorporated by keratocytes cultured in DMEM/F12
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alone eluted between fractions 16 and 21, with only some of the incorporated
35

SO4 eluting between fractions 26-31. This suggests that the presence of growth

factors in the medium for cells plated at low density or plating cells at high
density is necessary to prevent the degradation of proteoglycans. This may
explain why the keratocan signal was lower in low density control plated
keratocytes than keratocytes plated at high density. The core proteins of the
proteoglycans may be degraded and not detected by Western blot, but the

35

SO4

incorporated in the residual GAG chains is detectable. The growth factors may
be playing a role in protecting the secreted proteoglycans from proteolysis or
stimulating the production of a cell product that stabilizes proteoglycans. The
proteoglycans produced by keratocytes plated at high density are not degraded
in the absence of growth factors. This suggests that plating density may play an
important role in proteoglycan stability and accumulation.

It is possible that

keratocytes secrete other ECM components that interact with the proteoglycans
in the medium, and that at low density the unstimulated keratocytes do not
secrete enough ECM components to prevent the degradation.
Insulin acts through its transmembrane receptor and modulates several
metabolic processes with respect to glucose, lipids and proteins (169). Insulin’s
interaction with its receptor also activates members of the MAPK family and
results in cell proliferation as well (169,170). We have shown that keratocytes will
proliferate in DMEM/F12 supplemented with insulin or ITS without the loss of the
dendritic morphology or the keratocyte markers ALDH and keratocan. This
suggests that keratocytes are expressing the insulin receptor in culture. Insulin is
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also required for the maintenance of the adipocyte phenotype (183) and the
addition of insulin to the medium of activated hepatic stelleate cells results in the
upregulation of putative adipogenic transcription factors resulting in the cells
returning to their quiescent, pre-myofibroblastic state (184)
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Figure 1. 3H-Thymidine incorporation by keratocytes in culture. Keratocytes
plated at 5,000 cells/cm2 were radiolabeled for 72-hours starting on days 1 and 4.
The cell layers were harvested, the DNA precipitated in 10%TCA using BSA as a
carrier and incorporation determined per µg of DNA.
Legend: Open bars: thymidine incorporated from day 1 to day 4; filled bars:
thymidine incorporated from day 4 to day 7.
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Figure 2. Measurement of DNA content of keratocyte cultures. Cell layers of
keratocytes plated at low (5,000 cells/cm2) (A) and high (20,000 cells/cm2) (B)
were harvested on day 1, prior to growth factor treatment, and then at 72-hour
time intervals after the growth factors were added over the 6 day study period.
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Figure 3. Representative Western blots of keratocytes for ALDH, and
medium for keratocan. All samples obtained from control cultures at high
density. Lane 1, cytosolic ALDH is detected as a 53-kDa band. Lane 2,
keratocan in the medium is detected by the antibody as a smear of 80-160 kDa
size. Lane 3, the ‘medium’ is digested with endo-β-galactosidase and the core
protein of keratocan is detected as a band at 51 kDa.
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Figure 4. Pixel densities of ALDH content of the cell layers (A) and
keratocan in the medium (B).

The Western blots using antibodies against

ALDH (A) were scanned and the pixel density of each band determined. The
pixel density value was divided by the µg of DNA in the culture. Keratocytes
plated at low (open bars) and high (filled bars) density and cultured for 7-days.
(B)

Cell medium for keratocytes at low and high density were collected,

concentrated 150 or 50-fold (low and high density, respectively), the medium
equivalent to 3 wells (low density) or half a well (high density) digested with
endo-b-galactosidase, separated by SDS-Page and blotted against keratocan
core protein. The bands were scanned and their pixel density determined. The
measured pixel density was then divided by the DNA content of each culture. At
low density (open bars) insulin, ITS and PDGF-BB stimulate keratocan secretion,
while at high density (filled bars) keratocan accumulated in the medium of all
culture conditions. Bar represents mean of 3 determinations plus SD (for both A
and B).
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Figure 4
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Figure 5. Superose 6 gel-filtration chromatography of accumulated
proteoglycans. Elution profiles of incorporated 35SO4 in the media at day 4 of
low (A) and high-density (B) keratocyte cultures. The elution positions of decorin
(open bar), keratocan (black bar) and PDGS are indicated. The elution positions
were determined by immunodotblots (data not shown).
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Figure 6. Morphology of keratocytes in culture. Keratocytes plated at low
density were photographed after 7 days in culture. The medium was replaced
every 72 hours. Control (A), FGF-2 (B), insulin (C), ITS (D) and PDGF-BB (E).
The control cells, as well as cells in insulin or in the insulin containing medium
ITS maintain a dendritic morphology, while cells in FGF-2 and PDGF-BB appear
fibroblastic.

101

PAPER 3:

STIMULATION OF COLLAGEN SYNTHESIS BY INSULIN AND
PROTEOGLYCAN ACCUMULATION BY ASCORBATE IN BOVINE
KERATCYTES IN VITRO

Kurt Musselmann, Bradley Kane, Bridgette Alexandrou and John R. Hassell
From the Department of Molecular Medicine, College of Medicine University
of South Florida, 12901 Bruce B. Downs Boulevard, MDC Box 7,
Tampa, Florida 33612

Address correspondence to John R. Hassell, Tampa, FL 33612, Tel. 813-9747881 E-mail: jhassell@health.usf.edu
This work was supported by a grant from the National Institute of Health
EY08104
(to J. R. H.)
ACCEPTED FOR PUBLICATION ON AUGUST 11TH, 2006

102

SUMMARY
Purpose: Ascorbate is required for the hydroxylation of collagen that is present in
the corneal stroma. The keratan sulfate proteoglycans (KSPGs) lumican and
keratocan, are also present and they interact with collagen and modulate its
assembly into fibrils. In this study, ascorbate was added to a defined medium
containing insulin and its effects on the synthesis of collagen and KSPGs by
keratocytes was determined.
Methods: Collagenase isolated keratocytes were cultured with or without insulin
with or without ascorbate. Collagen and glycosaminoglycan synthesis were
determined by collagenase digestion of incorporated 3H-glycine and by
chondroitinase ABC or endo-β-galactosidase digestion of incorporated 35SO4.
KSPGs were detected by Western blot. Collagen stability was determined by
pepsin digestion. Ethyl-3,4-dihydroxybenzoate (EDB) was used to inhibit
collagen hydroxylation.
Results: Insulin stimulated the synthesis of collagen but did not affect the
accumulation of lumican and keratocan. Insulin plus ascorbate, however,
stimulated the synthesis of collagen and increased the accumulation of these
proteoglycans. The accumulation of PGDS, a KSPG that does not interact with
collagen, was not affected by ascorbate. Only the collagen made in the
presence of ascorbate was pepsin resistant. EDB overrode the effects of
ascorbate on pepsin resistance and proteoglycan accumulation.
Discussion: The results of this study indicate that the accumulation of lumican
and keratocan depends, in part, upon the level of collagen synthesis and its
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hydroxylation. The interaction of lumican and keratocan with the stably folded
triple helix provided by hydroxylation may also serve to stabilize these
proteoglycans.

INTRODUCTION
The corneal stroma contains keratocytes imbedded in an extracellular
matrix consisting primarily of collagen types I and V and of proteoglycans that
contain either chondroitin sulfate (CS) or keratan sulfate (KS) chains. Electron
microscopic studies show the corneal stroma contains collagen fibrils of small,
uniform diameter that are separated by small, uniformly sized spaces. The
collagen fibrils in the corneal stroma are heterofibrils of collagen types I and V (33).
Collagen type V is essential for the initiation of fibril formation (37) and the
presence of collagen V in the heterofibril has been shown to limit the fibril diameter
growth (34). The proteoglycans are in the spaces between the fibrils in vivo (25)
and in vitro assays that measure collagen fibril assembly have shown that these
proteoglycans modulate collagen fibril formation (185,186). Collagen fibril
formation in the presence of CS and KS proteoglycans purified from the cornea
delayed fibril formation, decreased the rate of fibril growth and resulted in smaller
collagen fibrils (44). The removal of the GAG side chains did not affect the activity
of the proteoglycans, but reduction and alkylation abolished the activity. This
indicates that the core protein of these proteoglycans modulates collagen
assembly into fibrils (44,180). The major proteoglycans of the corneal stroma are
decorin (187) , lumican (188,189) and keratocan (41). Decorin is a CS
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proteoglycan, whereas keratocan and lumican are KS proteoglycans. Keratocan
(52,157) and lumican (5,155,156) null mice have thinner corneas, and the collagen
fibrils in the stromas are larger and less organized than in the stromas of normal
mice, confirming the in vitro turbidimetry analysis of collagen fibril assembly.
Taken together, these findings indicate that collagen type I assembly into fibrils is
modulated by both collagen type V and the keratan sulfate proteoglycans in the
stroma.
Three procollagen polypeptides come together to form a left-handed triple
helix immediately after synthesis (190,191). Stable triple helix formation, however,
can only occur if certain lysine and proline residues in the collagen molecule are
hydroxylated (192). This post-translational hydroxylation is performed by either
lysyl or prolyl hydroxylases (193). These enzymes are found in the lumen of the
endoplasmic reticulum (191) and require ascorbic acid as a cofactor (194).
Ascorbate deficiency in cell culture does not affect collagen synthesis but affects
fibril formation and the rate of collagen secretion (195-197). The unhydroxylated
collagen molecules denature at a lower temperature and in less stringent
environments than properly hydroxylated collagen fibrils (198). Systemic
ascorbate deficiency leads to scurvy, and this deficiency affects wound healing.
Scorbutic wounds are weaker (199) than non-scorbutic wounds, prone to reopen
and contain a mass of irregular, unorganized collagen fibrils (200).
The cornea and anterior segment of the eye contain high levels of ascorbate
(201), where it is thought to function as an antioxidant and protect the cornea from
reactive oxygen species that result from UV irradiation (202,203). The levels of
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ascorbate in the aqueous humor and the cornea drop following an alkali burn
(204), resulting in the cornea becoming scorbutic. The cells in the stroma show
characteristics of scorbutic tissue such as a sparse ER, suggesting that they are
not very metabolically active (205). Topical ascorbate has been used successfully
to treat corneal alkali burns and has been proposed to do so by increasing the
synthesis and secretion of properly folded collagen to replace the collagen
denatured by the burn (206). In addition, topical ascorbate has also been used
post-photorefractive keratectomy (PRK) where its use decreased the late onset
corneal haze (207). Ascorbate concentration is highest in the epithelium, the layer
that is removed prior to PRK. While the exact reason for the late onset corneal
haze is not known, it is possible that removal of part of the epithelium prior to PRK
results in a drop in ascorbate levels in the anterior corneal stroma and we would
further speculate that this drop may reduce the secretion of properly folded
collagen which could result in the haze.
Ascorbic acid has been used to study collagen synthesis in culture (193),
but it is easily oxidized in solution and its metabolic by-products are cytotoxic in
extended cell culture (208). A stable, non-toxic phosphate derivative of ascorbic
acid (2-phospho-L-ascorbic acid) was developed (209) and has been shown to
stimulate collagen accumulation by skin fibroblasts in culture and also to enhance
the secretion of type I and type III collagen peptides by rabbit keratocytes cultured
in medium containing fetal bovine serum (210). Serum, however, contains
mitogens and morphogens that cause keratocytes in culture to proliferate, acquire
a fibroblastic morphology and cease keratocan expression (86,99,163). A
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chemically defined medium containing insulin has been previously shown to
stimulate keratocyte proliferation while maintaining their dendritic morphology as
well as keratocan expression (211). In this study, keratocytes were cultured in this
defined medium containing 2-phospho-L-ascorbic acid to determine its effects on
the synthesis and accumulation of collagen and KS proteoglycans.

MATERIALS AND METHODS
Chemicals
Chemicals were purchased from Sigma (St. Louis, MO) unless otherwise
indicated. Isotopes were obtained from PerkinElmer (Boston, MA). Invitrogen
(Carlsbad, CA) gels, reagents and equipment were used to separate proteins
and for transfer onto nitrocellulose.

Cell Culture
Keratocytes were isolated from adult bovine corneas using two sequential
collagenase digestions as previously described (139). Cells were plated in
DMEM/F12 at high density (20,000 cells/cm2) in 6-well plates (Costar,
Cambridge, MA) and allowed to attach overnight at 37ºC in 5% CO2. The
medium was changed the next day (day 1) and on days 4, 7 and 10 to fresh
DMEM or DMEM supplemented with insulin (10 µg/ml), with or without 1mM 2phospho-L-ascorbic acid (ascorbate). Ethyl-3,4-dihydroxybenzoate (EDB) was
added at 0.08mM and 0.4 mM final concentration on day 1.
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DNA quantitation
Cell layers were harvested on days 1, 4, 7 and 10 to measure DNA content
using Cyquant (Invitrogen, Carlsbad, CA). Briefly, the cell layers were rinsed
with PBS, frozen, thawed and solubilized in a lysis buffer supplemented with a
DNA binding dye.

The DNA content was determined at 480/535nm by

measuring 4 wells in triplicate and comparing the values to a calf thymus DNA
standard. The DNA content of parallel cultures was measured for experiments
that utilized the cell layer.

Cell proliferation
Cultures were radiolabeled with 20µCi

3

H-thymidine/ml of medium for 72h

beginning on days 1 and 4. The labeled medium was removed upon harvesting,
and the cell layers washed with cold PBS. The cell layers were processed as
described under DNA quantitation. Incorporation into DNA was determined as
previously described (139).

Collagen synthesis
The incorporation of 3H-glycine into collagen was determined as previously
described (212-214). In summary, cultures were incubated for 72h in medium
containing 25µCi 3H-glycine/ml beginning on day 1. Media was adjusted to 4M
guanidine HCl and the cell layers extracted in 4M guanidine HCl. Unincorporated
isotope in media and cell layers was removed by chromatography on PD10
columns equilibrated and eluted with 4M guanidine HCl (GE Healthcare,
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Piscataway, NJ). Fractions containing incorporated radioactivity were pooled,
dialyzed against water and 400 µl aliquots incubated with or without 2.5 Units
collagenase form III (Advanced Biofactures, Lynbrook, NY) in collagenase
digestion medium (3mM N-ethyl maleimide, 50 mM Tris pH 7.5, 150mM NaCl
and 5 mM CaCl2) for 3 hours at 37˙C. Undigested proteins were precipitated
with carrier BSA using cold 10%TCA containing 0.5% tannic acid and released
incorporated counts measured by liquid scintillation.

The DNA content was

determined as described above.

Collagen helix stability
Medium from cells was adjusted to 0.5M acetic acid and concentrated 8-fold
using Amicon Ultra spin-concentrators MWCO 10,000 (Millipore Corp., Bedford,
MA). 50µl of a 4mg/ml pepsin solution (in 0.5M acetic acid) per 3 ml was added
and the samples rocked overnight at 4˚C. Each sample received a second 50µl
aliquot from the pepsin stock, and digestion was allowed to continue for an
additional six hours at 4˚C. The samples were titrated with 1N NaOH to pH 8.0
to inactivate the enzyme, dialyzed against water overnight, lyophilized,
reconstituted in 1X SDS running buffer and separated on 10% bis-tris gels under
reducing conditions.

The gels were stained with Safestain following the

manufacturers protocol.
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Proteoglycan synthesis
Cultures were labeled with 50 µCi/ml of

35

SO4 for 72 hours on day 1.

The

medium was collected, frozen, lyophilized and reconstituted in 4M guanidine HCl.
Unincorporated isotope was removed using PD10 columns. Fractions containing
incorporated

35

SO4 were combined and concentrated using Amicon Ultra spin-

concentrators. Incorporation into CS and KS was determined by digestion with
chondroitinase ABC or endo-β-galactosidase (Seikagaku, Associates of Cape
Cod, E. Falmouth, MA) as previously described (211).

Aliquots containing

equivalent incorporated radioactivity were fractionated using a Superose 6 12/30
HR column (GE Healthcare, Piscataway, NJ) equilibrated and eluted with 4M
guanidine HCl (0.05 NaAc, pH6.5) at 0.3 ml/min.

Fractions (0.6 ml) were

collected and incorporation measured by liquid scintillation counting. The levels
of CS and KS in each fraction were determined as described above.

Western blot analysis
Core protein and protein levels in the media were measured by Western blot as
previously described (211). In brief, the culture media was collected from each
culture condition, concentrated by spin filtration to one tenth or one fiftieth of the
original volume. The size of the aliquot needed from each sample to provide a
similar signal on film by Western blot was empirically determined. The measured
pixel density was then divided by the DNA content of the culture equivalent to the
amount loaded and expressed as pixel density per µg DNA. Blots were probed
with polyclonal antibodies to bovine keratocan or lumican (diluted 1:1000) or
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prostaglandin D synthase (PGDS) (1:20,000). The lumican and keratocan
antibodies are peptide antibodies raised against the core protein (100).

The

rabbit antiserum to bovine PGDS was a generous gift of Gary J. Killian (Penn
State University). Membranes were rinsed and incubated for 1 hour in 1:10,000
horseradish peroxidase (HRP)-conjugated secondary IgG (GE Healthcare,
Piscataway, NJ).

Protein bands were visualized using ECL(GE Healthcare,

Piscataway, NJ) on Kodak Bio-Max XAR X-ray film. Band density was measured
using a Bio-Rad GS-710 Calibrated Imaging Densitometer (Bio-Rad, Hercules,
CA).

Statistical Analysis
Statistical analysis was performed using Statview (SAS Institute, Cary, NC).
Samples were analyzed using a paired t-test. Standard error was used when
n>3 and standard deviation used when n=3

RESULTS
The DNA content of the keratocyte cultures was measured over a 10-day
culture period to determine if ascorbate stimulated cell accumulation. The cells
cultured in DMEM/F12 or DMEM/F12 medium supplemented with ascorbate did
not increase in number, but keratocytes cultured in medium supplemented with
insulin increased in number over the 10-day culture period (Figure 1).

Cells

cultured in insulin plus ascorbate show a moderately higher initial accumulation
rate than keratocytes cultured in insulin in the absence of ascorbate and
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achieved the same density on day 7 as cells in insulin did on day 10.

The

incorporation of 3H-thymidine into DNA on days 1-4 and 4-7 reflected the cell
accumulation rates seen for all 4 culture conditions (data not shown).
The synthesis of collagen and proteoglycans was measured over 72h
beginning on day 1 and ending on day 4, a time period during which the cell
number was rapidly increasing in the cultures receiving insulin.

3

H-glycine

incorporation into collagen was determined by sensitivity to collagenase digestion
(Figure 2). Compared to control, keratocytes cultured in ascorbate synthesized
40% less collagen (p<0.05), and this decrease was in the collagen associated
with the cell layer.

Keratocytes cultured in insulin synthesized 4-fold more

collagen (p<0.01), with increases of 5-fold in the cell layer (p<0.02) and 3-fold in
the medium (p <0.03). Cells cultured in both insulin and ascorbate synthesized
7-fold (p=0.0004) more collagen compared to controls; a value 50% greater than
insulin alone (p=0.006). Compared to keratocytes cultured in insulin alone, the
medium of keratocytes cultured in insulin plus ascorbate contained 4-fold more
collagen (p < 0.001) but the cell layer contained 30% less collagen (p <0.03).
Keratocytes cultured in ascorbate plus insulin synthesized 11-fold more collagen
than keratocyte cultured in ascorbate alone with a 9-fold increase (p<0.001) in
the cell layer and a 12-fold increase (p<0.001) in the medium.

This data

suggests that insulin stimulates collagen synthesis and that ascorbate increases
the proportion of the collagen that is secreted into the media.
The hydroxylation of proline in the procollagen molecule is a posttranslational modification required for the formation of a stable triple helix in the
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endoplasmic reticulum.

Prolyl hydroxylases are the enzymes required for the

hydroxylation of the 4-position of proline. Ethyl-3,4-dihydroxy-benzoate (EDB) is
a selective inhibitor of prolyl hydroxylase (215). EDB is not toxic to the cells and
has been previously shown to inhibit collagen deposition in a dose-dependent
manner (215-217). Since most of the collagen made by keratocytes cultured in
ascorbate plus insulin was in the media (Figure 2), the collagen in the media was
analyzed for stability by resistance to pepsin digestion.

Keratocytes were

cultured in insulin or insulin plus ascorbate-containing medium with or without
0.4mM EDB.

The medium of the cells was collected, adjusted to 0.5M acetic

acid, digested with pepsin and analyzed by SDS-PAGE (Figure 3). The medium
of keratocytes cultured in insulin plus ascorbate contained pepsin-resistant
collagen types I and V fibrils, demonstrated by the prominent bands for α1(I) and
α2(I), as well as a clear band for α1(V) between the 64 and 191kDa markers
(Figure 3, lane IA). The band for α2(V) partially co-migrated with α1(I), but can
be observed as a faint band just above α1(I) (Figure 3, right panel, expanded
view of lane IA). These bands were absent in the medium of cells cultured in
insulin alone (lane I) and in the medium of cells cultured in insulin, ascorbate and
0.4mM EDB (lane IAE). These results show that the 2-phospho-L-ascorbic acid
derivative of ascorbate acts on collagen to produce a stably folded triple helix.
The accumulation of lumican and keratocan in the culture medium was
determined by Western blot.

The medium was digested with endo-β-

galactosidase to remove the KS side chain before SDS-PAGE to facilitate
transfer in Western blot. Antibodies to the core protein of the proteoglycan detect
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the core protein as a sharp band in a Western blot (211), and the pixel density for
each band was determined (Figure 4).

Treating cells with ascorbate alone

increased keratocan and lumican levels in the medium 4-fold (p < 0.005), but
insulin alone had no effect on the levels of these proteoglycans.

A 9-fold

increase in both lumican and keratocan was observed (p < 0.005 for both), when
cells were cultured with insulin plus ascorbate. Prostaglandin D synthase (PGDS)
is also synthesized as a KSPG by keratocytes in vitro (139). Consequently, we
performed Western blots for PGDS as well and found that neither ascorbate nor
insulin affected PGDS levels.

Since only keratocan and lumican have been

shown to interact with collagen fibrils (44), these results suggest that the
increased accumulation of KSPGs in the medium is limited to those with core
proteins that interact with collagen.
Having shown that the accumulation of lumican and keratocan in the
medium is increased by the addition of ascorbate, we then tested if the
stimulatory activity of insulin plus ascorbate could be inhibited by the addition of
EDB at a low and high dose (0.08 mM and 0.4 mM, respectively). As previously
shown, the addition of ascorbate to medium containing insulin increased lumican
and keratocan accumulation, but the presence of 0.08mM EDB in medium
containing insulin and ascorbate reduced the accumulation of both lumican and
keratocan by 19 and 28% (p<0.01) respectively after 72h (Figure 5). EDB at a
high dose (0.4mM) reduced lumican and keratocan (p=0.07) accumulation in the
medium to levels below of those measured in insulin alone. The level of PGDS
also declined but the decrease was not significant (p=0.5). The results of this
114

experiment also confirm a correlation between hydroxylation and increased
levels of lumican and keratocan production.
Keratocyte cultures were radiolabeled with

35

SO4, and the amount of

incorporated radiolabel in the CS and KS secreted into the media was
determined by digestion with chondroitinase ABC and endo-β-galactosidase to
35

determine if ascorbate would also increase the incorporation of

SO4 into KS

(Figure 6). Compared to control, the addition of ascorbate alone did not increase
the incorporation of

35

SO4 into either CS or KS and insulin caused only minor

changes in the incorporation of

35

SO4 into these glycosaminoglycans. Culture in

insulin plus ascorbate, however, increased

35

SO4 incorporation into both CS and

KS significantly (p <0.01), but preferentially enhanced incorporation into KS (11fold for KS, 6-fold for CS), compared to control.
While most of the keratan sulfate made by keratocytes in culture has been
shown to be in proteoglycans, a portion accumulates as free GAG in the medium
(211). These GAG side chains may be the result of proteolytic degradation of the
core proteins. Consequently, equivalent counts of incorporated

35

SO4 present in

the medium of insulin or the medium of insulin plus ascorbate treated cultures
were fractionated on Superose 6 to separate intact proteoglycans from GAGs.
The intact proteoglycans synthesized by keratocytes cultured in insulin or in
insulin plus ascorbate eluted between fractions 15 and 23 (Figure 7). There was,
however, relatively greater incorporation in fractions 19 to 23 for keratocytes
cultured in insulin plus ascorbate.
chondroitinase

ABC

or

Fractions 15-23 were digested with

endo-β-galactosidase
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to

determine

the

glycosaminoglycan chain composition. The inlay shows that over 80% of the
incorporated counts in fractions 15-18 were released by chondroitinase ABC
digestion, whereas over 60% of the incorporated counts in fractions 19-23 were
released by endo-β-galactosidase digestion.

This demonstrates that the KS

containing proteoglycans elute primarily in fractions 19-23, and further confirms
that ascorbic acid preferentially stimulates the synthesis of KS containing
proteoglycans.

DISCUSSION
The results of this study indicate that ascorbate alone does not increase
collagen synthesis by keratocytes in culture.

The addition of insulin alone,

however, increased collagen synthesis 4-fold and the presence of ascorbate in
medium containing insulin further increased collagen synthesis to 7-fold. The
further increase in total collagen synthesis is likely due to the ascorbate-mediated
hydroxylation of prolines and lysines in the collagen molecule that stabilizes the
triple helix and thereby increases its secretion and resistance to degradation.
Insulin has been shown to stimulate collagen type I synthesis in human lung
fibroblasts at both the mRNA and protein levels(218), and to stimulate
collagenous protein accumulation in scleroderma fibroblasts via the PKC-gamma
pathway(219). Insulin therapy has been shown to improve wound healing of skin
burns in rats(220).

Insulin treatment has also been shown to improve the

strength of healed through-and-through wounds in rabbit corneas(221). Since
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tissues derive their tensile strength from collagen, the increased strength of the
corneal wounds treated with insulin may be due to increased collagen synthesis.
The addition of ascorbate to culture medium containing insulin not only
stimulated collagen synthesis, but also increased keratocan and lumican
accumulation 9-fold and KS synthesis 11-fold.

The increase in lumican and

keratocan accumulation correlates with the increased synthesis of hydroxylated
collagen. Culture in insulin alone stimulated collagen synthesis, but did not affect
lumican and keratocan accumulation.

Although insulin stimulated collagen

synthesis in the absence of ascorbate the collagen did not form stable triple
helices, as shown by a greater proportion of the total collagen made
accumulating with the cell layer, or pericellularly(205), and by the susceptibility of
the collagen secreated into the medium to degradation by pepsin.

When

ascorbate was added to the insulin-containing medium, a higher proportion of the
total collagen made was secreted into the medium and the collagens type I and V
present in the medium were pepsin resistant.

The effect of ascorbate on

stimulating lumican and keratocan accumulation and providing resistance of
collagen to pepsin digestion was abolished when ethyl-3,4-dihydroxybenzoate
(EDB) was added to the culture medium. EDB is an analogue of ascorbate and
competitively

inhibits

prolyl

hydroxylase,

resulting

in

the

synthesis

of

underhydroxylated collagen (217). Taken together, these data suggest that the
synthesis and accumulation of lumican and keratocan are linked to the level of
collagen synthesis and to the stabilization of the collagen triple helix by
hydroxylation.
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The ascorbic acid mediated stimulation of keratan sulfate proteoglycan
accumulated by keratocytes was limited to keratocan and lumican.

Both

keratocan and lumican have core proteins containing leucine rich repeats (LRR)
(222,223). Homology modeling of proteins with LRR to ribonuclease inhibitor
show that these proteins to fold to a solenoid tertiary structure (47,189,222,223),
that interacts with the collagen fibril and regulates fibril formation and diameter
(44). PGDS is made as a keratan sulfate proteoglycan by keratocytes in culture
(139), but it does not contain LRR and does not interact with collagen. Unlike
keratocan and lumican, PGDS accumulation was not affected by insulin,
ascorbate or the combination of both.
Our studies that show that while insulin stimulated collagen synthesis,
most of this increase was in the collagen associated with the cell layer and that
when ascorbic acid was included with insulin, most of the increase was in the
collagen secreted into the medium, where the proteoglycans are also secreted.
Proteoglycans such as lumican and keratocan that interact with collagen may
depend on the formation of a stable collagen helix for their own stability. The core
protein of these proteoglycans interact with specific regions of the collagen fibril
(224-226) in a manner similar to the interaction of collagen with decorin (227).
The decreased stability of the collagen triple helix that forms in the absence of
ascorbate would weaken if not abolish the interaction of the core protein with the
collagen. The other possibility is that the core proteins for lumican and keratocan
are also hydroxylated and this stabilizes their structure and prevents proteolytic
attack. It may be interesting to note that elastin, another extracellular matrix
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component, is also hydroxylated in the presence of ascorbate (228). There is,
however, no evidence that the prolines or lysines in lumican and keratocan are
hydroxylated and the increased synthesis of these proteoglycans in the presence
of ascorbic acid is more likely due to a protective effect they receive by
interaction with a stably folded collagen.
Our study shows that ascorbate, besides stabilizing the collagen triple
helix, also increases the accumulation of lumican and keratocan proteoglycans in
the medium. This data suggests that the prophylactic action of ascorbate in
alkali wound treatment (206,229), and in the prevention of late onset corneal
haze after PRK by the use of topical ascorbate (207), may be due to the effect of
ascorbate on increasing the stability of the triple helix for collagen I and V which
then acts to increase the stability and therefore the accumulation of the keratan
sulfate proteoglycans lumican and keratocan. The increased accumulation of
keratan sulfate proteoglycans, in turn, may accelerate the restoration of stromal
transparency by regulating the assembly of the stably folded collagen triple
helices into fibrils of the correct diameter. Insulin, which we and others (219)
have shown to stimulate collagen synthesis and which has been shown to
improve wound healing (220,221), may further enhance wound healing if used in
combination with ascorbate, particularly in humans, since they lack the ability to
synthesize ascorbate.
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Figure 1. Keratocyte population growth in culture using defined media.
Legend: Control, filled squares solid line; ascorbate, open squares dashed line;
insulin, filled triangles solid line; insulin plus ascorbate, open triangles dashed
line. The addition of ascorbate to the culture medium increases initial growth rate
when insulin is present in the medium but does not affect final cell density or
growth in the absence of insulin. n=4
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Figure 2. Collagen synthesis and secretion in defined media. Cultures were
incubated in media containing 3H-glycine for 72 hours. Radioactivity
incorporated into collagen present in the media (black bar) and cell layer (open
bar) was determined using a collagenase specific for fibrillar regions of collagen.
The addition of ascorbate alone did not alter the collagen synthesis. Adding
insulin to the culture medium significantly increased collagen in both the cell layer
and the medium. Insulin plus ascorbate show a significant increase collagen in
secreted into the medium and a significant decrease in collagen in the cell layer
compared to insulin alone. n=3

121

Figure 3. SDS PAGE analysis of medium digested with pepsin. The medium
of cells cultured in insulin (I), insulin plus ascorbate (IA) or insulin, ascorbate and
EDB (0.4mM) was collected, concentrated and digested with pepsin in 0.5M
acetic acid. Aliquots of the digested samples and a pepsin only control (P) were
separated on 10% bis-tris and stained for total protein using SafeStain. Only the
medium of cells cultured in insulin and ascorbate had pepsin resistant collagen.
The IA lane is shown expanded to the right and the migration positions of the
chains for collagen I and V are labeled.
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Figure 4. Accumulation of keratan sulfate proteoglycans in the medium.
Medium was collected on day 4, digested with endo-β-galactosidase, separated
by SDS-PAGE, transferred to nitrocellulose and probed with antibodies to
keratocan, lumican or PGDS. The Western blots using antibodies against
keratocan, lumican and PGDS were scanned to determine their pixel density and
the net pixel density divided by the micrograms of DNA in each culture. Bars
represent the mean of 3 determinations plus S.D. Keratocan accumulation in
medium containing ascorbate increased 4-fold (p < 0.005) compared to control.
Medium containing insulin and ascorbate contained 9-fold more keratocan and
lumican (p < 0.005) than control medium. The addition of ascorbate did not have
an effect on PGDS levels with or without insulin. n=3
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Figure 5. Accumulation of keratan sulfate proteoglycans in culture medium
of cells treated with ethyl-3,4-dihydroxybenzoate (EDB). Keratocytes were
cultured in medium containing either 0.08mM or 0.4mM EDB in insulin containing
growth medium with or without ascorbate. Samples were processed as
described in Figure 6. A dose dependent significant decrease (p < 0.01) at
0.08mM EDB was detected in both lumican and keratocan accumulation between
cells cultured in insulin + ascorbate and insulin + ascorbate + EDB. At 0.4mM,
lumican and keratocan levels fell below the levels of the insulin alone control.
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Figure 6. Incorporation of 35SO4 into glycosaminoglycans during 72h in
culture. Cultures were incubated in medium containing 35SO4 for 72 hours. The
culture medium was collected, sensitivity of incorporated radioactivity to
chondroitinase ABC (open bars) and endo-β-galactosidase (solid bars) digestion
was used to determine incorporation of 35SO4 into chondroitin and keratan
sulfate, respectively. CPM was expressed per µg of DNA. Bars represent mean
plus S.D., n=3.
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Figure 7. Chromatography of 35SO4 radiolabeled proteoglycans on
Superose 6. Culture medium from keratocytes incubated with 35SO4 for 72hours was harvested and equal amounts of incorporated radioactivity was
fractionated on Superose 6 to determine incorporation into intact proteoglycans.
Legend: insulin: filled squares, solid line; insulin plus ascorbate: open squares,
dashed line. Inlay shows percent CS/KS of fractions 15 to 23 from media of
insulin plus ascorbate treated cells. Inlay legend: CS, solid line; KS, dashed line.
Most of the incorporated radioactivity elutes at the position of the intact
proteoglycans. Ascorbate preferentially stimulates the incorporation of 35SO4 into
KSPG.
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DISCUSSION

The study of keratocytes in culture has changed considerably in the last
ten years, most notably since the use of a serum-free medium (SFM) for culturing
these cells (98) and its adaptation to the bovine keratocyte culture system (98).
Previous work showed that FGF-2 stimulated keratocytes to grow faster than
they do in 10% serum (178). Keratocyte culture research conducted as part of
this dissertation, however, failed to replicate those results. Closer examination
showed that this study had used low concentrations of serum (0.1%) in their
culture medium, suggesting that the presence of serum was affecting the potency
of the growth factors. This was tested in supplement to paper 1 figure 1. A large
increase in thymidine incorporation was observed when serum was present in
the plating or in the culture medium, even at low concentrations. Keratocytes,
plated in medium containing serum and cultured in 0.1%PPHS incorporated
significantly more thymidine than cells plated and cultured in SFM. A significant
increase was also observed when comparing the stimulation of thymidine
incorporation caused by growth factors acting on keratocytes in SFM or
keratocytes exposed to serum. Even the stimulation of thymidine incorporation
by extract increased when keratocytes were exposed to serum at plating or
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during culture. In summary, exposure to serum affected the response of the
keratocytes to growth factors.
Viewing the results from paper one, the supplement and paper two as a
whole suggests the following explanation for these results. Culture in extract
stimulates all cells to grow equally (paper 1, figure 3), but FGF-2 and PDGF-BB
may stimulate only some of the cells to grow when cultured in the absence of
serum (paper 2, figures 1 and 2). These cells thrive in culture medium containing
FGF-2 or PDGF-BB, proliferate and become fibroblastic, while the cells in extract
remain dendritic.

Supplementing the medium with serum, at plating time or

during culture, affects the cell-cycle state of some keratocytes and also enhances
the cellular response to FGF-2 and PDGF-BB.

It is known that exposure of

serum, followed by serum starvation, increases growth factor receptor expression
(230).

It is possible, therefore, that when the serum present at plating is

removed, keratocytes increase the expression of receptors to FGF-2 and PDGF
and respond stronger to these growth factors. Another possible explanation for
this is the fact that serum is a complex medium, and contains a mixture of
mitogens, morphogens, proteins, lipids, carbohydrates and nutrients.

Even

though PPHS is less rich in mitogens than FBS, it likely still contains other
proteins (231-233) that affect cells, and in this case, keratocytes in culture. In
our laboratory, PPHS was originally added to facilitate and speed up cell
attachment, however, it was found that keratocytes started to attach within 15
minutes and this was delayed if PPHS was present in the culture medium. In
addition, Beales et al. (99) showed that plating keratocytes in 1% PPHS altered
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their CS/KS ratio. Berryhill et al. (100) also showed that when the stimulation by
10% serum was removed, the cells only partially reverted to the keratocyte
phenotype.

All these experimental observations suggest that serum, either

PPHS or FBS, even at low concentration, affect the way keratocytes respond to
growth stimuli, although they may still maintain a dendritic morphology.
Following these observations, the use of 1% PPHS as a plating supplement was
discontinued and only SFM used to plate the keratocytes.
An unexpected result obtained in the second paper was the 60-fold
increase in keratocan accumulated in the medium of keratocytes plated at high
density when compared to the medium of cells plated at low density. While this
result raised the possibility that proteoglycan synthesis was density-dependent,
the size exclusion chromatography provided an explanation (Paper 2, figure 6).
It is now evident that keratocytes at low density degrade most of the
proteoglycans they secrete. This degradation was prevented if keratocytes were
plated at high density, or cultured in the presence of growth factors. It is known
that MMP 2, a collagen-degrading protease, is present in the unwounded cornea
and that its synthesis and activity increase significantly after corneal wounding
(234,235). However, this MMP is present in an inactive form, and is activated
after proteolytic cleavage of the pro-domain (236).
Chakravarti et al. have shown that keratocytes plated in SFM upregulate
mRNA levels of MMP 13 and MMP 3, possibly via an autocrine loop involving IL1a (237). IL-1a has also been shown to induce MT1-MMP (MMP 14) expression
in smooth muscle cell culture as early as 4-hours after stimulation (236). MT1129

MMP is present in the corneal stroma (238), and can activate pro-MMP 2 to the
active enzyme (239). Therefore, it is possible that keratocytes at low density
increase IL-1a secretion, resulting in increased MT1-MMP synthesis and MMP 2
activation.
In the presence of growth factors, IL-1a secretion or MMP activation may
be downregulated. Insulin, for instance, has been shown to prevent excessive
proteolytic degradation of tissues after burn wounds (240), but this may be due to
the anabolic effect of insulin (241), and not to the prevention of ECM
degradation. Studies have also shown that these growth factors increase the
expression of tissue inhibitors of metalloproteases (TIMP) in a cell-specific
manner (242). Keratocytes have been shown to secrete TIMP1 and TIMP1 is
present in the corneal stroma (243). If TIMPs are upregulated by these growth
factors could therefore provide a possible explanation to the decreased
degradation.
A possible explanation for the lack of degradation observed at high plating
density is that at under these conditions the keratocytes reestablish cell-cell
contacts via dendritic processes, similar to what is observed in the unwounded
stroma (58). This may in turn prevent the secretion of IL-1a, the activation of
MT1-MMP via downstream signals (244) or both, reducing protease activity. At
low plating density, keratocytes are not contact-inhibited, in a manner similar to
the one observed after the apoptotic event following corneal wounding. The cellvoid space (64) that results from apoptosis still contains the intact ECM and this
dense stromal ECM should be viewed as an obstacle for cell migration.
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Regardless, keratocytes repopulate the cell-void space within a couple of days
after injury and do so by migrating through the ECM. The changes in GAG side
chain size, and increased CS content (86), affects the organization of the stromal
ECM (127), and may make it easier for the cells to migrate through it, but it is
also possible that keratocytes in the migratory stage exhibit tumor-cell like MT1MMP expression, and this allows them to degrade the ECM at the leading edge
of the migrating cells. The upregulation of matrix degrading enzymes such as
MT1-MMP by keratocytes may therefore be an important factor for the migratory
phase of the wound healing response.

It is also possible, however, that

keratocytes produce and secrete other proteases into the medium or
environment and that these are responsible for the degradation observed in lowdensity cultures. These could include members of the cathepsin proteases (245)
family or serine proteases like urokinase, which have been shown to be activated
during wound healing in the cornea (246).

As one of the functions of the

keratocytes in-situ is to remodel the ECM, it is possible that the proteolytic action
of these cells is part of the keratocyte phenotype. Increased degradation, as a
result of the loss of cell-cell contacts, may result in the release of growth factors
sequestered in the ECM, increasing their availability.

Increased proteolytic

activity, therefore, may be a result of the apoptotic event, increasing growth
factor availability as well as causing limited destabilization of the stromal ECM
that will allow keratocyte migration into the cell-void space. Upon re-formation of
the cell-cell contacts and the keratocyte network, this proteolytic activity may
decrease again to the pre-wound, housekeeping levels.
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The proposal that keratocytes plated at low density are more
proteolytically active is further supported by the increased incorporation of sulfate
when keratocytes at low density were cultured in the presence of bovine serum
albumin (BSA) (Supplement Figure 2 A.) and the lack of a peak containing free
GAG side chains (Supplement Figure 2 B and Paper 2, Figure 6 A.) in low
density cultures. BSA significantly increased proteoglycan accumulation even at
low concentrations (0.001%), and increasing concentrations of BSA had little
effect on total sulfate incorporation at both low and high plating density. While
BSA may stimulate uptake of radiolabeled sulfate by the cells, thereby increasing
incorporation, it is also possible that this ‘stimulation’ is the result of reduced
degradation of the radiolabeled proteoglycans.
The newly synthesized and radiolabeled proteoglycans are present at
concentrations that are significantly lower than the BSA in the medium and
therefore shielded from proteolytic degradation by the excess of BSA in the
medium.

SFM supplemented with 0.1mg/ml BSA contains a total protein

concentration similar to the one measured in 10% extract (0.1 mg/ml).
Equivalent counts of synthesized proteoglycans in the medium of keratocytes at
low (B) and high (C) plating density were fractionated using Superose 6
(Supplement figure 2 B and C) and the results show that the elution profiles of
sulfate incorporated by cells cultured in extract or 0.1mg/ml BSA are nearly
identical, and significantly different that the incorporation by keratocytes at low
density, where a large peak between fractions 28-32 (free GAG side chains) is
detected. Additionally, the stimulation of sulfate incorporation was not lost if the
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extract was denatured by heat or by 4 M guanidine and correlates to the protein
contents of the extract fractions (data not shown).

Furthermore, a 1mg/ml

ovalbumin solution also stimulated sulfate incorporation (data not shown). It is
still possible that the BSA or the mitogens present in the extract do stimulate
sulfate incorporation, but it seems more likely that the presence of extract or BSA
prevents the degradation of the newly synthesized, radiolabeled material by
shielding them from degradation.
As the results of paper 3 show, the accumulation of proteoglycans
secreted by keratocytes cultured in medium containing ascorbate is enhanced
due to the hydroxylation of collagen.

Extract, due to its origin, contains

ascorbate, as well as other proteins extracted from the pulverized stroma. It is
possible that it contains collagens, and that the newly synthesized proteoglycans
are interacting with this collagen in solution and also during synthesis. It is also
possible that the BSA added interacts with the proteoglycans being secreted, and
stabilize them in solution in a manner similar to the collagen-proteoglycan
interactions, thereby preventing their degradation.
One of the questions remaining to be answered is the origin of the
mitogenic activity of the extract. Is this activity only found in the stroma, or can it
be found in other parts of the eye. To test whether extract from other parts of the
eye affected keratocyte growth, extracts from lens, retina and vitreous humor
were made.

With the exception of the lens extract, none of the extracts

stimulated thymidine incorporation (Supplement Figure 3). As described in the
introduction, the corneal epithelium originally forms from the same cells that give
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rise to the lens epithelium, so it is possible that the lens epithelium secretes
growth factors that affect keratocyte cell growth, in a manner similar to growth
factors made by the corneal epithelium.
In the scrape wound model discussed in the introduction, keratocytes
repopulated the cell-void space within 5 days.

Keratocytes in the stroma

adjacent to the wound margin appeared Ki67 positive after around 16-hours post
scrape, indicating that these cells have left G0 and have re-entered the cell cycle
(64). Other studies show that keratocytes re-enter the cell cycle 12-15 hours
post wounding. Keratocytes cultured in extract begin incorporating thymidine into
DNA 15-hours after the initial exposure.

This suggests that the keratocytes

released by the digestion of the corneal stroma remain in G0, and are only
stimulated to enter the cell cycle in the presence of growth factors present in
extract or serum. Zieske et al. (64) have shown that the keratocytes that enter
the cell cycle are those immediately adjacent to the cell-void space.

In

accordance with Wilson, who has hypothesized that apoptosis is the initiating
event of the wound healing response (247), they proposed a model in which
apoptotic keratocytes release factors into the extracellular environment that
stimulate neighboring cells to proliferate (64). In this model, the same cytokine at
a high concentration would produce an apoptotic response, and when found in a
low concentration activate keratocytes to proliferate.

To determine if the

mitogenic action of the extract was due to an apoptotic response during extract
preparation, the freshly isolated stromas were frozen rapidly on dry ice prior to
extraction. It is unlikely that the cells undergo apoptotic cell death in the short
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period of time between the isolation of the stroma and the freezing on dry ice.
This, however, did not affect the potency of the extract, suggesting that the
mitogens are already present in the stroma and are not the result of the
homogenization procedure. This observation resulted in an optimized method to
prepare stromal extract (presented in the appendix).
Furthermore, the process by which cells are isolated from the corneal
stroma should induce some keratocytes to undergo apoptotic cell death.

If

keratocytes are activated by this apoptotic event, then the plated cells should
proliferate, at least initially, in culture. Yet, this is not observed. Keratocytes
plated out in DMEM/F12 remained quiescent and incorporated negligible
amounts of thymidine (Supplement Figure 1). When keratocytes were plated at
low density and cultured in the stromal extract, the mitogenic response of the
cells was equivalent to the response observed in serum, but a significant
reduction in the mitogenic potency of the extract was observed when cells were
plated at intermediate or high densities.

Additionally, the BrdU incorporation

study shows that in the micromass cultures most, if not all, the incorporation
takes place at the periphery of the culture, an area in which the keratocytes are
not in close contact with other cells. Furthermore, cell culture data show that
keratocytes cultured in extract grow to a lower final density than cells cultured in
serum, even though the cells are maintained in extract, and are still exposed to
the mitogen. These results indicate that keratocytes only undergo mitosis in
extract if they are not contact-inhibited by other cells. All this evidence suggests
that it is the loss of cell-cell contacts as a result of keratocyte apoptosis that
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activates the surviving keratocytes to proliferate, and not the actual apoptotic
event. Keratocytes in the stroma are interconnected by lamellipodia both within
the same lamellae and through the lamellae. It is therefore possible that after
wounding, damaged nerve cells, or epithelial cells release an initiator of
apoptosis, which affects the neighboring keratocytes. This apoptotic signal then
travels through the stroma from keratocyte to keratocyte away from the injury
site. Keratocytes exposed to a signal level released from the dying cells over a
treshold limit undergo apoptotic cell death. As the cell density of the anterior
stroma is higher than in the middle and posterior stroma, the surface insult to the
cornea would result in a larger number of anterior keratocytes undergoing
apoptosis.

As this signal travels into the middle and posterior stroma, the

strength of the signal would decrease due to the decrease in keratocyte density
in these parts of the stroma, resulting in the formation of the bowl shaped cellvoid space detected after wounding. When the signal is too dilute to cause cell
death, the keratocytes adjacent to this space have lost their neighbors and are
no longer contact-inhibited.
This leads to the following model for keratocyte activation (Discussion
Figure 1):

Corneal wounding causes the formation of a cell-void space by

necrosis and/or apoptosis. The loss of keratocytes near the injury area results in
the loss of cell-cell contacts of the cells flanking the wound margin and in
consequence the loss of contact inhibition. These cells can now respond to the
mitogens already present in the stroma. They become activated, re-enter the cell
cycle become migratory and undergo one round of division.
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Some of the

daughter cells will be contact-inhibited by neighboring cells, and exit the cell
cycle. The cells at the new cellular margin, however, remain responsive to the
mitogens and continue to proliferate and migrate. This process continues until
the advancing cell fronts meet, at which point contact inhibition forces the cells to
exit the cell cycle and become ‘quiescent’ again.

If the mitogens found in the stromal extract are indeed the mitogens that
activate keratocytes in the initial stage of wound healing, then culture in the
extract would be expected to cause changes similar to those observed during
corneal wound healing. The stromas of wounded corneas during the initial phase
of repair contain more chondroitin sulfate than keratan sulfate. If the mitogens
present in the extract are indeed the mitogens that activate keratocytes in vivo,
chondroitin sulfate synthesis should increase comparatively to keratan sulfate
synthesis. Adding extract to keratocytes stimulated total sulfate incorporation per
cell 11-fold when compared to DMEM alone (Supplement Figure 4, left panel).
Most of the incorporated sulfate was sensitive to chondroitinase ABC, suggesting
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that the increase was in chondroitin sulfate GAGs (Supplement Figure 4, right
panel). Western blots of extract or the medium of keratocytes cultured in extract
did not detect biglycan (not shown), suggesting that the increase is in decorin
expression. It is possible that this increase is due to increased sulfation of the
GAG sidechain or an overall increase in core protein synthesis. However, it is
also possible that the determination of keratan sulfate content of the cells in
extract is too low, as the keratan sulfate accumulated during the wound healing
response is less sulfated (86).
Activated keratocytes contain significantly less ALDH when compared to
keratocytes and reflect more light (85), increasing stromal haze. This decrease
in cytosolic ALDH could be the combination of both dilution of the protein after
each round of division and degradation of the ALDH via the ubiquitin pathway
(87).

A complete loss in the levels of cytosolic ALDH was detected after

extended culture in extract. Compared to the cytosol of keratocytes cultured in
DMEM alone for 8 days, the cytosol of cells cultured in extract contain no
detectable ALDH band (Supplement Figure 5B). The intensity of the ALDH band
of cells cultured in extract had decreased considerably by day 4 and was gone by
day 8. In healed corneal wounds, keratocyte reflectivity decreases over time as
haze subsides, suggesting that the intracellular levels of ALDH should increase
once cells have reached confluency.

However, stromal haze is at times still

present several months after corneal wounding, suggesting that this recovery is
slow and may take several months. The increased reflectivity of the keratocytes
after wounding explains the ‘halo’ effect experienced after refractive surgery and
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that eventually subsides. The in vivo wound healing observations suggest that
ALDH levels should increase in the cells cultured in extract after these cells have
reached confluence, but this was not tested beyond two weeks.
It is known that the activated keratocytes can become myofibroblastic by
the action of TGF-b both in vivo and in vitro (89,98,248,249).

Keratocytes

activated by extract were incubated in the presence of extract with or without
5ng/ml TGF-b for 8 days. A change in morphology by the activated keratocytes
was evident by day 4 (Supplement figure 5 A). Instead of maintaining a dendritic
morphology and intercellular spacing, these cells appeared myofibroblastic and
covered the culture dish.

Western blots for the fibrotic markers fibronectin,

SPARC and a-SMA confirmed the presence of these proteins in these cultures
and also the absence of cytosolic ALDH (Supplement Figure 5 B). TGF-b is not
usually present in the corneal stroma, but enters the stroma after damage to the
corneal epithelium and disruption of the basement membrane (250). Eyesight
corrective surgeries involving the ablation of the basement membrane, like
photorefractive keratectomy (PRK), often are followed by the development of
stromal haze in the photoablated area (248) due to the presence of
myofibroblastic keratocytes in this area (95).

In contrast, myofibroblastic

keratocytes after laser assisted keratomileusis (LASIK) surgery, if at all present,
are usually limited to the area where the microkeratome cut through the
epithelium and the basement membrane (104) with none being present in the
photoablated portion of the cornea (95). This indicates that the myofibroblastic
differentiation of the activated keratocytes is brought on by the disruption of the
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basement membrane and the release of cytokines from the damaged epithelium.
This disruption allows these growth factors to enter the stroma, act on the
activated keratocytes and causes them to adopt the myofibroblastic phenotype
(Discussion Figure 2).

The mitogenic activity in the extract fractionated under physiologic salt
conditions by gel filtration eluted in the high-molecular weight range.

The

molecular weight of most known growth factors range between 6-30 kD, but the
mitogens in the extract eluted at over 200 kD. The ease of extraction, suggested
that the mitogens would not be very tightly bound in the stroma, and therefore
should be able to diffuse throughout the matrix. To test if the mitogens were part
of a larger protein complex, the stromal extract was exposed to both strong
denaturants and NaCl at increasing concentrations. The presence of high salt
shifted the elution of the mitogens by one fraction and broadened the peak
(Supplement Figure 6A), suggesting that mitogenic activity in the extract was part
of a complex and was held together partially by charge-charge interactions.
When strong denaturants, like 4 M guanidine or 8 M urea were used during the
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fractionation, most of the mitogenic activity of the extract was lost and not
recovered (not shown). This suggests that the mitogenic activity of the extract is
in part due to the concerted action of the components of the complex. Adding
mild denaturing conditions and detergent to physiologic salt first resulted in a
significant broadening of the elution position of the mitogens, but increasing the
salt concentration eventually resolved the mitogenic activity into two peaks
(Figure 6B.). The dissociation of the mitogenic complex in 1M urea suggests that
the high molecular weight complex containing the mitogens is also held together
by protein-protein interactions. The proposal that the mitogenic activity in the
extract is part of a larger complex is further confirmed when the extract was
fractionated by herparin sepharose (Figure 7).

When neat extract was

fractionated on the column, most of the activity did not to bind to the column and
elute with the pass through (PT). The fractions eluted with 0.5M NaCl (low salt,
LS) or the 2 M NaCl (high salt, HS) had little stimulatory activity on their own.
When combined, however, thymidine incorporation increased 7-fold over the HS
eluate, and 20-fold over the LS eluate, indicating a synergistic effect increase on
activity. This suggests that some of the required components of the complex
were separated and eluted in the LS fraction and in the HS fraction, and that
these components need to be together to stimulate cell growth. No change in
thymidine incorporation was detected when the fraction eluted in LS was added
to the PT. However, when the PT, LS and HS fractions were combined, the
combined fractions stimulated thymidine incorporation more than 2-fold
compared to the PT alone and at least 80% more than the sum of the PT, LS and
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HS fractions (and 50% over the sum of the PT plus the LS+HS complex),
suggesting that components in all three fractions are important and act
synergistically to stimulate cell growth.
Taking all chromatography data of the extract together suggest the
following hypothesis. The complex containing mitogenic activity in the stromal
extract interacts with other components of the matrix via charge-charge and
protein-protein interactions.

Given the high levels of sulfated GAGs in the

stroma, it is plausible that the complex containing the mitogenic activity is bound
to proteoglycans. These proteoglycans do not bind heparin and therefore are
found in the PT fraction. The binding by parts of the complex to the GAG side
chains is likely weak and can be affected by using urea or high concentration of
salt. Therefore, I propose that at least a part of this complex can diffuse through
the stroma, binding GAG side chains.

To summarize, the presence of all

components of the complex and their proper folding are important for the cellular
interaction and likely determine the mitogenic potency of the extract, and
disruption of the complex, or of its folding, affects the cellular response.
FGF-2 and PDGF-BB have been shown to stimulate keratocyte cell
growth. Neutralization studies, using antibodies to these growth factors were
performed to test whether these growth factors were responsible for the
mitogenic activity found in the extract (Supplement Figure 8). The incubation of
extract with neutralizing antibodies to FGF-2 or PDGF-BB did not affect the
mitogenic potency of the extract.

These results, combined with the

morphological data published in the second manuscript, suggest that the activity
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in extract is not due to either FGF-2 or PDGF. Immunostaining has shown that
the receptors for both insulin and IGF-I are found in the corneal stroma
(171,251). While the insulin receptor is specific, the IGF-1 receptor binds IGF-I,
IGF-II and insulin, but with varying affinities. Consequently, insulin and IGF-I
were also tested. Like FGF-2 and PDGF-BB, IGF-I was not detected in the
extract by Western blot, nor neutralized by its antibody. The insulin antibody use
did not neutralize the activity of purified insulin, and the alternative method used
to determine the insulin contents of the extract did not detect any (data not
shown).
A possible explanation for the negative results of the IGF-I neutralization is
the fact that members of the IGF family are not usually found free in solution.
They bind strongly to one of six binding proteins (IGFBP1-6), and these binding
proteins both stabilize and sequester the IGFs in solution (252).

While the

binding of IGF to the binding protein can reduce its mitogenic activity, some
IGFBPs have been shown to enhance the activity of IGF by facilitating the
binding of the mitogen to its receptor (253). IGFBP2 mRNA has been detected in
the developing eye (254), but not in the mature cornea (252,255). However, a
recent study shows that the expression of IGFBP3 is increased during the
corneal wound healing response (256). The existence of an IGFBP3 receptor
has been described (253), but this has not been tested in keratocytes. Because
of their high affinity for each other, it should be assumed that if IGFs were
present in the extract, they would also be bound to IGFBPs. This binding may
have interfered with the binding of the antibody in the neutralizing study. The
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binding of IGFs to IGFBPs can result in the formation of high molecular weight
complexes (~140 kD), and it has been shown that IGFBPs can bind to
glycosaminoglycans (257). This observation would fit the results presented in
paper 1 and also in the supplement.

Identification of one of the mitogens in extract
It is known that insulin, besides interacting with its own insulin receptor,
has affinity to the IGF-1R, albeit with a lower specificity than IGF-I or II. Due to
the high concentrations of insulin used in the cell culture medium in papers 2 and
3, it is possible that the activity of insulin is the result of a combined activation of
both the insulin receptor and IGF-1R. Even though the initial Western blot for
IGF-I was negative and the IGF-I antibody did not neutralize the mitogenic
activity of the extract, the extract was re-examined for the presence of IGF-I and
IGF-II. New antibodies to IGF-I and IGF-II were obtained, and the Western blots
repeated. The Western blot using antibodies to IGF-I was negative (not shown),
however, the blot using antibodies to IGF-II showed that IGF-II is present in the
extract (Discussion Figure 3.A). Furthermore, thymidine incorporation studies
show that keratocytes are stimulated by IGF-II to incorporate thymidine in a
manner similar to extract (Discussion Figure 3.B).
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Next, the S300 fractions containing mitogenic activity were analyzed for
IGF-II by Western blotting, and the later eluting peak that stimulated thymidine
incorporation was positive for IGF-II (Discussion Figure 4). However, no IGF-II
was detected in the early eluting peak and therefore it is likely that these fractions
contain different mitogens. These results suggests that the mitogenic activity,
present in the stroma, is due to at least two distinct mitogens, one of which is
IGF-II.
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IGF-II expression in the cornea, however, was previously shown to only take
place during corneal development, and not by mature keratocytes.

Mature

keratocytes, however, express IGFBPs as a result of corneal wounding. The
origin of the IGF-II in the corneal stroma, therefore, still remains unknown. Lens
epithelial cells have been shown to produce IGFBP2 (258), and IGFBP2 is
present in the aqueous humor. Cells in the ciliary body have also been shown to
make IGFBP2, and may also secrete IGF-II into the aqueous humor (254). As
the cornea is avascular, and because of the leaky nature of the endothelium, it is
possible that both the IGFBP2 and IGF-II found in the stroma are of lens or ciliary
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body origin, and are diffusing into the stroma from the aqueous. This would
explain why the lens extract had a stimulatory effect on keratocytes (Supplement
Figure 3).

A recent publication has shown that decorin binds IGF-I (259), but it

is not known whether it can also bind IGF-II.

The IGF-II present in the stroma,

would likely be bound to IGFBPs in the stroma and this complex may be
associated with the GAGs in the stroma. Such an association would explain the
high apparent molecular weight of the extracted mitogen under non-dissociating
conditions. Chromatography in buffer containing high salt, or mild denaturing
conditions would result in the partial dissociation of the complex, explaining the
shift in the elution position of the mitogenic activity.

At strong denaturing

conditions, the complex responsible for the mitogenic activity would not only be
completely dissociated, but also irreversibly denatured and not able to stimulate
thymidine incorporation. This would inhibit the formation of the complex, even
after dialysis and therefore inhibit binding to possible surface receptors and
abolish its mitogenic activity.
IGF-II is a growth factor usually associated with fetal development, and
has been identified in the corneal stroma early in development. The expression
of IGF-II mRNA decreases as the mesenchymal cells become keratocytes
(260,261) and no expression is found by keratocytes in the mature cornea.
Unlike other wounds in the body, which usually result in scar tissue, many
corneal wounds recover a degree of organization after wounding that is similar to
the ECM prior to the wounding event, and little evidence of a scar remains
(43,127). Cintron et al. also observed that during the healing of a full thickness
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wound in a young rabbit, the events taking place in the stroma appear to recreate
the events of early corneal development and the generation of corneal
transparency (3,43,127).

It is therefore interesting to have identified that the

cornea contains a growth factor that is normally involved in the development of
the eye, and that in the adult tissue may be responsible for the initiation of the
wound healing response.
IGF-II is a member of the insulin like growth factor family (262). It has a
molecular weight of ~7.5 kDa and shares ~75% sequence homology with IGF-I
(263). IGF-II can bind to three extracellular receptors (262,264). It binds to both
the IGF-1R and a specific splice variant of the insulin receptor (264). IGF-II also
interacts with a third receptor, the mannose 6-phosphate receptor/IGF-II
receptor, however, this receptor acts only as a clearance receptor removing IGFII from the extracellular environment and does not participate in growth factor
signaling (262). Both the IGF 1R and the insulin receptors are tyrosine kinase
receptors composed of two identical a and b subunits (265). Upon binding of
IGF-II to the IGF 1R, the trans-membrane b subunits autophosphorylate and then
serve as docking sites for insulin receptor substrate (262)and Shc adaptor
proteins (264). The IGFs regulate many different signaling pathways, for
example, they can recruit phosphatydil inositol 3’ kinase (PI3 kinase) (265),
which would then activate the mitogen-activated protein kinase (MAP kinase) and
PI3 kinase cascades (265), eventually leading to the transcription of specific
genes important for cell survival, differentiation or proliferation (262,264,265).
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CONCLUDING REMARKS

Three keratocyte phenotypes have been observed in vivo. The in situ,
quiescent keratocyte, the activated keratocyte involved in the initial stage of
wound healing and the myofibroblastic keratocyte responsible for the deposition
of the fibrotic ECM. The aims of this dissertation were to develop culture media
that would allow the study of these phenotypes. In the course of this study three
major findings were made.
The first finding is that the presence of serum, at plating or during culture,
alters the response of keratocytes to growth factors, without affecting the cellular
morphology. Consequently, the presence of serum, even at low concentrations,
modifies the cellular response to cytokines and therefore should not be used to
culture keratocytes.

IL-1, which was shown to induce apoptosis of corneal

fibroblasts (keratocytes in serum) (107), fails to do so in and actually stimulates
growth of quiescent keratocytes (162).
The second finding is that the corneal stroma is preloaded with mitogens
and that these mitogens are not secreted by keratocytes during apoptosis.
These mitogens are proteins, can diffuse throughout the stroma, are different
from the mitogens found in serum and are part of a large complex at
physiological salt concentrations. This complex is partially held together by ionic
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interactions, suggesting that it can bind to GAGs in the stroma and also held
together by protein-protein interactions. Culture of keratocytes with the stromal
extract replicates the changes observed in keratocytes both in vivo and in vitro
during the activation process. These mitogens stimulate sulfate incorporation,
but some of the increase in sulfate synthesis may be due to the presence of BSA
or proteins in the extract shielding the newly synthesized proteins from
degradation.

IGF-II, a member of the insulin like growth factor family, was

detected in one of the high molecular weight peaks containing activity in the
extract. It was not, however, found in the first peak, suggesting that the corneal
stroma may contain more than one mitogen responsible for the activation of the
keratocytes after wounding. Keratocytes only express IGF-II during the early
development of the cornea and not at maturity (261), so the IGF-II detected in
stromal extract may have been made earlier.
The third finding is that medium containing insulin supplemented with
ascorbate can be used to grow keratocytes in culture and maintain their normal
phenotype.

Insulin stimulated the synthesis of collagen and ascorbate is

necessary for proper collagen folding which, in turn, increased the accumulation
of the KSPGs that accumulate with collagen as well.

Inhibiting collagen

hydroxylation eliminated both increases, indicating that formation of a stable
triple helix by collagens is important for the synthesis and stability of collagens
and of these proteoglycans. Keratan sulfate proteoglycans are important for the
proper assembly of collagen into fibrils needed for the maintenance of stromal
transparency.
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This research shows that keratocytes can be grown in culture medium
supplemented with insulin and ascorbate and maintain their phenotype. Culture
in medium containing stromal extract recreates in vitro the phenotypes observed
in vivo in the initial phase of the wound healing response, and extract
supplemented with TGF-B recreates the myofibroblastic phenotype. Although
IGF-II was identified as one of the mitogens in the stromal extract, it is likely that
other mitogens are still present. IGF-II, however, can now be recognized as one
of the natural mitogens in the cornea and its action on keratocytes be studied in
culture. Stromal extract, like serum, is a complex medium, but due to the nature
of its origin, contains the components of the liquids that bathe the keratocytes insitu. Therefore, it should be used preferentially to FBS to activate keratocytes in
vitro. The results obtained by culture in extract also suggest that, unlike ALDH
and keratocan and contrary to what has been reported in the literature,
keratocyte morphology should not be considered a marker solely for the
‘quiescent’ phenotype.

Future directions
The research presented in this dissertation is only in its initial phases.
Several questions remain open, and ought to be studied further.

The exact

nature and the cellular origin of the complex containing the mitogenic activity in
the stroma is not known. The identification of the components of the complex, by
proteomic, chromatographic or other methods is important, and will provide
researchers with a possible explanation for its origin and its mechanism of action.
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The activation of keratocytes during the wound healing response has been
extensively reported and studied in vitro.

The mechanism and the mitogens

involved in the activation, however, are not known as of this writing.

The

identification of IGF-II as one of the mitogens present in the stroma is
encouraging as IGF-II was shown to replicate the proliferation observed in
extract, but the failure to detect IGF-II in the first peak, containing most of the
mitogenic activity indicates that other mitogens play a role.
Once the mitogens, and the components of the complex are identified,
then the dissection of the actual mechanism of action can begin. What are the
cellular origins of the components of the mitogenic complex? Are keratocytes
interacting with the mitogenic complex constantly, and prevented from
responding to it by the downregulation of signaling intermediates because of
contact inhibition? It is likely that the ‘quiescence’ of the keratocytes observed in
the unwounded stroma is just the result of the network of cells resulting in contact
inhibition.

Once the components of the complex have been identified, then

immunohistochemistry studies could show where the complex is located in the
stroma and what its relation to the keratocytes is.
Could the complex require proteolytic cleavage by keratocytes to become
fully active? This would be especially interesting, as the research presented in
this dissertation has shown that keratocytes degrade the proteoglycans they
secrete when plated at low density.

The activity of the extract is both dose

dependent and cell density dependent.

Again, the identification of the

components of the extract is important to determine if this may be going on.
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However, preliminary studies using extracts on cells isolated from cartilage
showed that mitogens in extract also stimulated cellular proliferation in some of
those cells. This proliferation may be due to the activity of IGF-II, and not of the
other mitogens present in extract.
Keratocytes contain f-actin filaments, which are re-organized as the result
of activation. Immunofluorescence studies staining for focal adhesions and factin would show if this is occurring in the keratocytes cultured in extract or
insulin.

Activated keratocytes, besides being proliferative, are migratory.

Keratocytes cultured in extract express the a5b1 integrin, important for the
migration of cells on a fibronectin matrix. With a proper experimental setup, it
would be possible to detect and measure cell migration in the presence of
extract, without having to use methods that block cell proliferation.

Once a

proper experimental method is developed, it will be possible to detect whether
the migrating keratocytes express proteolytic enzymes such as MT1-MMP at the
leading edge.
IGF-II was identified as one of the mitogens in the extract.

The data

suggest, however, that another mitogen may be present in the stromal extract as
well. This discovery is rather new, and still needs to be examined in more detail.
It is possible that IGF-II may only stimulate the cells to proliferate, and not result
in the other phenotypic changes observed in activated keratocytes. If this were
the case, then medium containing IGF-II as well as ascorbate, instead of medium
containing insulin and ascorbate, should be used to expand keratocyte
populations in vitro.
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An important difference between the growth in extract and the growth in
the purified growth factors is that the cells in extract grow at a very fast rate.
Keratocytes cultured in growth factors, in contrast, grow at a slower, constant
rate. Is the maintenance of the keratocyte phenotype dependent on the rate of
growth?

It could be argued that the rapid repopulation of the stroma after

wounding is an important evolutionary characteristic. A slower rate of growth,
with the maintenance of the keratocyte markers, may be more important in the
repopulation of the stroma due to lesser cell death. This needs to be further
studied, and if determined, may significantly move forward the development of
artificial tissue. The cells, for example, could be grown in medium containing
extract in the initial phase, and then the medium slowly exchanged with medium
containing insulin and ascorbate (or IGF-II and ascorbate).

This would then

stimulate the keratocyte phenotype, even though the cells would still be dividing,
albeit at a slower rate.
The exact mechanism of ascorbate-induced KSPG synthesis requires
further elucidation.

Our experimental setup does not provide a sequence of

events for this upregulation. It is possible that the properly folded collagen is
secreted into the medium, binds to integrin receptors on the cellular surface, and
then upregulates KSPG synthesis. It is also plausible that the newly synthesized
proteoglycans are interacting with the nascent procollagen chains in the ER, and
are protected from intracellular degradation by this interaction. Future studies
may seek to focus on these observations, and determine the sequence of events.
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Recent studies have shown that primary keratocytes can be grown in
pellet cultures (266,267), and do not lose the expression of keratocan even if
grown in the presence of serum. In the pellet cultures, the cells secrete and form
an extracellular matrix.

Data presented at Funderburgh et al. (268) at the

Association for Research in Vision and Ophthalmology held in Fort Lauderdale in
2006, show that the collagen fibrils accumulated by keratocytes appear to form
lamellae in vitro. Future studies should try to blend keratocyte culture in cell
pellets with the ascorbate supplemented growth medium here developed.
Amniotic membrane has also been used to grow keratocytes in vitro and
maintain their phenotype (269).

As the amniotic membrane surrounds the

developing fetus, it may contain IGF-II, and as contains an extracellular matrix,
which may contain other components that are important for the proper
conformation of the active factors in extract.
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APPENDIX A

Method to prepare stromal extract
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1. Scrape the epithelium of the cornea off using a #10 scalpel blade and excise
the cornea using a #11 scalpel blade.
2. Remove the endothelium by blotting against filter paper
3. Snap freeze the corneas by placing them on aluminum foil placed over dry ice
4. After the corneas are frozen solid, place in pre-weighed 50 ml conicals, weigh
again and freeze noting the weight of the added corneas
5. Add solidly frozen corneas into a Waring blender chilled with and still
containing liquid Nitrogen, and pulverize the corneas, 10 at a time, for 30
seconds at a high speed setting.
6. Pour the pulverized stromas into 10 volumes of DMEM/F12 of total cornea
weight to be pulverized. Repeat until all corneas have been used. Stir at
room temperature for 30 minutes to thaw the corneas.
7. Continue stirring for 330 minutes (5.5 hours) at 4C
8. Pour slurry into polycarbonate tubes, and spin down insoluble material at
20,000x g for 15 minutes at 4 C
9. Pour cleared supernatant into 35 ml polycarbonate tubes. Spin at 33,000 rpm
in a Ti5200 for 60 minutes to precipitate remaining insoluble material.
10. Sterilize extract by filtering using a 0.2 um filter unit. Aliquot 5 or 10 ml into 15
or 50 ml conicals, and freeze at -80 C until ready to use. This is 100% extract.
11. Prepare a thymidine incorporation curve for the batch to determine the
concentration that gives the maximum thymidine incorporation.
12. Before use, thaw the required amount, add fresh 1X DMEM/F12, and use as
culture medium.
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